ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or Other Jurisdiction of Incorporation or Organization) |
(I.R.S. Employer Identification No.) |
Title of each class |
Trading Symbol |
Name of each exchange on which registered | ||
Large Accelerated File |
☒ |
Accelerated Filer |
☐ | |||
Non-Accelerated Filer |
☐ |
Smaller Reporting Company |
||||
Emerging growth company |
Page |
||||||||
Item 1. |
2 |
|||||||
Item 1A. |
18 |
|||||||
Item 1B. |
38 |
|||||||
Item 2. |
38 |
|||||||
Item 3. |
39 |
|||||||
Item 4. |
39 |
|||||||
Item 5. |
40 |
|||||||
Item 6. |
42 |
|||||||
Item 7. |
42 |
|||||||
Item 7A. |
75 |
|||||||
Item 8. |
76 |
|||||||
Item 9. |
124 |
|||||||
Item 9A. |
124 |
|||||||
Item 9B. |
125 |
|||||||
Item 9C. |
125 |
|||||||
Item 10. |
126 |
|||||||
Item 11. |
126 |
|||||||
Item 12. |
126 |
|||||||
Item 13. |
126 |
|||||||
Item 14. |
126 |
|||||||
Item 15. |
127 |
|||||||
Item 16. |
131 |
|||||||
132 |
• | Broad Offering of Differentiated Products with Advanced System-Level Features and Functions. |
• | Fast Time-to-Market |
• | Ability to Deliver Cost Competitive Solutions. |
• | Focus on Delivering Highly Energy-Efficient Products. run-time, environmentally friendly and energy-efficient consumer electronic products. In addition, there is an increasing regulatory focus on reducing energy consumption of consumer electronic products. As a result of a global focus on more environmentally friendly products, our customers are seeking analog and mixed-signal semiconductor suppliers that have the technological expertise to deliver solutions that satisfy these ever increasing regulatory and consumer power efficiency demands. |
• | Advanced Analog and Mixed-Signal Semiconductor Technology. |
• | Established Relationships and Close Collaboration with Leading Global Electronics Companies. |
innovators in the consumer electronics market. Our close customer relationships have been built based on many years of close collaborative product development, which provides us with deep system-level knowledge and key insights into our customers’ needs. As a result, we are able to continuously strengthen our technology in areas of strategic interest for our customers and focus on those products that our customers and end consumers demand the most. |
• | Longstanding Presence in Asia and Proximity to Global Electronics Devices Supply Chain. |
• | Broad Portfolio of Product Offerings Targeting Large, High-Growth Markets. |
• | Highly Efficient Manufacturing Capabilities. low-cost operating structure and improve our operational efficiency. We believe the location of our primary manufacturing and research and development facilities in Asia and the relatively low need for ongoing capital expenditures provide us with a number of cost advantages. |
• | Increase Business with Existing Customers. design-win rates. We seek to increase our customer penetration by more closely aligning our product roadmap with those of our key customers and take advantage of our broad product portfolio, our deep knowledge of customer needs and existing relationships to sell more existing and new products. |
• | Broaden Our Customer Base. |
• | Drive Execution Excellence. |
expect these ongoing initiatives will contribute to improvement of our new product development and customer service as well as enhance our commitment to a culture of quick action and execution by our workforce. In addition, we have focused on improving our manufacturing efficiency during the past several years. |
• | Return on Capital Investments and Cash Flow Generation. in-house manufacturing facility and external foundry to address a broad portfolio of power products while we seek to maximize return on capital investments and our cash flow generation. We intend to keep our capital expenditures relatively low by maintaining our focus on specialty process technologies that do not require substantial investment in frequent upgrades to the latest manufacturing equipment. However, from time to time, we make special investments to enhance our manufacturing capabilities by investing in new equipment and expanding our facility, which we expect will have a positive impact on our future new product development and revenue, particularly during the period of global shortage of capacity. |
• | Resolution and Number of Channels. |
• | Color Depth. TFT-LCD panels, 262 thousand colors are supported by 6-bit source drivers; 16 million colors are supported by 8-bit source drivers; and 1 billion colors are supported by 10-bit source drivers. |
• | Operational Voltage. |
• | Gamma Curve. |
• | Driver Interface. mini-low voltage differential signaling (m-LVDS), unified standard interface (USI) and mobile industry processor interface (MIPI). |
• | Package Type. |
• | Large Display Solutions. |
Product |
Key Features |
Applications | ||
TFT-LCD Source Drivers |
• 480 to 1,542 output channels • 6-bit (262 thousand colors), 8-bit (16 million colors), 10-bit (1 billion colors)• Output voltage ranging from 9V to 18V • Low power consumption and low EMI • COF package types • EPI, m-LVDS, USI interface technologies |
• LCD/LED TVs • Notebooks • LCD/LED monitors • Automotive | ||
TFT-LCD Gate Drivers |
• 272 to 960 output channels • Output voltage ranging from 30V to 45V • COF and COG package types |
• Tablet PCs • LCD/LED TVs • Notebooks • Automotive | ||
Timing Controllers |
• Wide range of resolutions • EPI, m-LVDS, MIPI, USI-T interface technologies• Input voltage ranging from 1.6V to 3.6V |
• Tablet PCs • Public information display | ||
OLED Source Drivers |
• 960 output channels • 10 bit (1 billion colors) • Output voltage: 18V • COF package type • EPI interface technology |
• OLED TVs | ||
Micro LED Drivers* |
• 552 output channels (3 Mux) • 10 bit (1 billion colors) • Output voltage: max 18V • COF package type • USI interface technology |
• Micro LED TVs |
* | In customer qualification stage |
Product |
Key Features |
Applications | ||
OLED |
• Resolutions of HD720, WXGA, FHD, FHD+, QHD and QHD+ • Aspect ratio from 16:9 to 21:9 • Color depth of 1 billion • MIPI, eRVDS interface • Logic-based OTP • Image enhancement IP • Display data compression IP |
• Smartphones • Game consoles • Digital still cameras • Tablet PCs • Virtual reality headsets • Automotive | ||
LTPS |
• Resolutions of VGA, WSVGA, WVGA and DVGA • Color depth of 16 million • MDDI, MIPI interface • Logic-based OTP • Separated gamma control |
• Smartphones • Digital still cameras | ||
a-Si TFT |
• Resolutions of WQVGA and HVGA • Color depth of 16 million • RSDS, MDDI, MIPI interface • CABC • Separated gamma control |
• Mobile phones • Digital still cameras • Automotive |
• | MOSFETs. low-voltage from 12V to 30V, medium-voltage from 40V to150V, high-voltage planar MOSFETs, 200V through 650V, and super junction MOSFETs, 500V through 900V. |
• | IGBTs. |
• | AC-DC/DC-DC AC-DC/DC-DC set-top boxes and display modules. We expect our AC-DC/DC-DC |
• | LED Drivers. |
• | Regulators. |
• | SSD PMICs. |
• | Logic PMICs. (T-CON) of OLED display panel with multi-channel power block (boost converter, buck converter, Op-Amps and positive/negative LDOs.) |
Product |
Key Features |
Applications | ||
Low Voltage MOSFET |
• Voltage options of 12V-30V • Advanced Trench MOSFET Process • High cell density • Advanced packages to enable reduction of PCB mounting area |
• Smartphones, mobile phones, and wearable devices • Tablet PCs, Notebooks • Desktop PCs, Servers • LCD/LED TVs • Industrial applications • Cryptocurrency miner | ||
Medium Voltage MOSFET |
• Voltage options of 40V-150V • Advanced Trench MOSFET Process • High cell density • High system efficiency • Advanced packages to enable reduction of PCB mounting area |
• e-Bikes and Motor controls• Battery Management Systems • Power tools and Servers • Other computing applications (Tablet PCs, Notebooks, Desktops) • Industrial applications • Automotive* |
Product |
Key Features |
Applications | ||
High Voltage MOSFET |
• Voltage options of 200V-650V • R2FET (rapid recovery) option to shorten reverse diode recovery time • Zener diode option for MOSFET protection for abnormal input • Advanced Planar MOSFET Process • Advanced packages to enable reduction of PCB mounting area |
• Adaptors for tablet PC/mobile phone/smartphone • Power supplies • Lighting (ballast, HID, LED) • Industrial applications • LCD/LEDTVs | ||
Super Junction MOSFET |
• Voltage options of 500V-900V • Low R DS(ON) • Epi stack process • Zener diode option for MOSFET protection for abnormal input • Advanced SJ MOSFET process • Advanced packages to enable reduction of PCB mounting area |
• LCD/LED/UHD TVs • Lightings applications (ballast, HID, LED) • Smartphones • Power supplies • Servers • Industrial applications | ||
IGBTs |
• Voltage options of 650V/1200V • Field Stop Trench IGBT • Current options from 15A to 100A |
• Automotive • Industrial applications • Consumer appliances | ||
AC-DC/DC-DC |
• Wide control range for high power application (>150W) • Advanced BCDMOS process • High Precision Voltage Reference • Very low startup current consumption • Fast load and line regulation • Accurate output voltage • OCP, SCP and thermal protections |
• LCD/LED/UHD TVs • Power supplies • Smartphones • Mobile phones • Notebooks • Set-top boxes | ||
LED Backlighting Drivers |
• High efficiency, wide input voltage range • Advanced BCDMOS process • OCP, SCP, OVP and UVLO protections • Accurate LED current control and multi-channel matching • Programmable current limit, boost up frequency |
• Tablet PCs • Notebooks • Smartphones • LED/UHD TVs • LED monitors |
Product |
Key Features |
Applications | ||
Digital Controlled LED Driver |
• Multi-channel constant current control • 12Bit gray scale with SPI |
• Digital signage | ||
LED Lighting Drivers |
• High efficiency, wide input voltage range • Simple solutions with external components fully integrated • Advanced high voltage BCDMOS process • Accurate LED current control and high power factor and low THB |
• AC and DC LED lighting | ||
Regulators |
• Single and multi-regulators • Low Noise Output regulators • Wide range of input voltage and various output current • CMOS and BCDMOS processes • LDO (Low Drop Out — Linear Regulator) |
• Smartphones and Mobile phones • Notebooks • Computing applications | ||
SSD PMIC |
• High current buck • PFM function • High frequency switching • High efficiency • High integration technology • Small QFN package |
• Computing applications | ||
Logic PMIC |
• High current boost • Integrated pass transistor • LDO • 3channel high current buck • Negative Charge Pump • 2channel buffer Op-Amp. • Tiny Wafer Level CSP |
• Notebooks • Tablet PCs |
* |
In customer qualification stage |
Name |
Age |
Position | ||||
Young-Joon (YJ) Kim |
57 |
Director and Chief Executive Officer | ||||
Shin Young Park |
41 |
Chief Financial Officer | ||||
Theodore Kim |
52 |
Chief Compliance Officer, General Counsel and Secretary | ||||
Woung Moo Lee |
59 |
General Manager of Worldwide Sales | ||||
Chan Ho Park |
58 |
General Manager of Power Solutions |
• |
We manufacture our products based on our estimates of customer demand, and if our estimates are incorrect, our financial results could be negatively impacted. |
• |
A significant portion of our sales comes from a relatively limited number of customers, the loss of which could adversely affect our financial results. |
• |
The average selling prices of our semiconductor products have at times declined rapidly and will likely do so in the future, which could harm our revenue and gross profit. |
• |
We are subject to risks associated with currency fluctuations, and changes in the exchange rates of applicable currencies could impact our results of operations. |
• |
Global shortages in manufacturing capacities could interrupt or negatively affect our operations, increase cost to manufacture and negatively impact our results of operations. |
• |
Expanded trade restrictions may limit our ability to sell to certain customers. |
• |
Recent changes in international trade policy and the imposition and threats of international tariffs, including tariffs applied to goods traded between the United States and China, could materially and adversely affect our business and results of operations. |
• |
Our Korean subsidiary has been designated as a regulated business under Korean environmental law, and such designation could have an adverse effect on our financial position and results of operations. |
• |
Our compliance with the Serious Accidents Punishment Act (the “SAPA”) could require significant expenditures and management time and expose us to liability for violations. |
• |
Our business depends on international customers, suppliers and operations in Asia, and as a result we are subject to regulatory, operational, financial and political risks, which could adversely affect our financial results. |
• |
We cannot guarantee that our share repurchase program will be successfully consummated, or that it will enhance shareholder value, and share repurchases could affect the price of our common stock. |
• |
Our Rights Plan and provisions in our charter documents and Delaware Law may make it difficult for a third party to acquire us and could depress the price of our common stock. |
• |
We have not historically paid dividends and do not currently have any dividend or distribution policy, and therefore, investors may need to rely on sales of their common stock as the only way to realize any future gains on their investments. |
• | our ability to offer cost-effective and high quality products and services on a timely basis using our technologies; |
• | our ability to accurately identify and respond to emerging technological trends and demand for product features and performance characteristics; |
• | our ability to continue to rapidly introduce new products that are accepted by the market; |
• | our ability to adopt or adapt to emerging industry standards; |
• | the number and nature of our competitors and competitiveness of their products and services in a given market; |
• | entrance of new competitors into our markets; and |
• | our ability to enter the highly competitive power management market. |
• | pay substantial damages or indemnify customers or licensees for damages they may suffer if the products they purchase from us or the technology they license from us violate the intellectual property rights of others; |
• | stop our manufacture, use, sale or importation of the accused products; |
• | redesign, reengineer or rebrand our products, if feasible; |
• | expend significant resources to develop or acquire non-infringing technologies; |
• | discontinue processes; or |
• | obtain licenses to a third party’s intellectual property. |
• | their earnings; |
• | covenants contained in any debt agreements to which we may then be subject, including any debt agreements of our subsidiaries; |
• | covenants contained in other agreements to which we or our subsidiaries are or may become subject; |
• | business and tax considerations; and |
• | applicable law, including any restrictions under Korean law that may be imposed on Magnachip Korea that would restrict its ability to make payments on intercompany loans from MagnaChip Semiconductor B.V. |
• | actual or anticipated variations in our results of operations from quarter to quarter or year to year; |
• | announcements by us or our competitors of significant agreements, technological innovations or strategic alliances; |
• | changes in recommendations or estimates by any securities analysts who follow our securities; |
• | addition or loss of significant customers; |
• | recruitment or departure of key personnel; |
• | changes in economic performance or market valuations of competing companies in our industry; |
• | price and volume fluctuations in the overall stock market; |
• | market conditions in our industry, end markets and the economy as a whole; |
• | subsequent sales of stock and other financings; and |
• | litigation, legislation, regulation or technological developments that adversely affect our business. |
• | authorize our Board of Directors to issue, without stockholder approval, preferred stock with such terms as the Board of Directors may determine; |
• | prohibit action by written consent of our stockholders; |
• | prohibit any person other than our Board of Directors, the chairman of our Board of Directors, our Chief Executive Officer or holders of at least 25% of the voting power of all then outstanding shares of capital stock of the corporation entitled to vote generally in the election of directors to call a special meeting of our stockholders; and |
• | specify advance notice requirements for stockholder proposals and director nominations. |
• | the transaction is approved by the board of directors before the date the interested stockholder attained that status; |
• | upon consummation of the transaction which resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced; or |
• | on or after such date, the business combination is approved by the board of directors and authorized at a meeting of stockholders, and not by written consent, by at least two-thirds of the outstanding voting stock that is not owned by the interested stockholder. |
• | any merger or consolidation involving the corporation and the interested stockholder; |
• | any sale, transfer, pledge or other disposition of 10% or more of the assets of the corporation involving the interested stockholder; |
• | subject to certain exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder; |
• | any transaction involving the corporation that has the effect of increasing the proportionate share of the stock of any class or series of the corporation beneficially owned by the interested stockholder; or |
• | the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits provided by or through the corporation. |
• | authorize our Board of Directors to issue, without stockholder approval, preferred stock with such terms as the Board of Directors may determine; |
• | prohibit action by written consent of our stockholders; |
• | prohibit any person other than our Board of Directors, the chairman of our Board of Directors, our Chief Executive Officer or holders of at least 25% of the voting power of all then outstanding shares of capital stock of the corporation entitled to vote generally in the election of directors to call a special meeting of our stockholders; and |
• | specify advance notice requirements for stockholder proposals and director nominations. |
• | the transaction is approved by the board of directors before the date the interested stockholder attained that status; |
• | upon consummation of the transaction which resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced; or |
• | on or after such date, the business combination is approved by the board of directors and authorized at a meeting of stockholders, and not by written consent, by at least two-thirds of the outstanding voting stock that is not owned by the interested stockholder. |
• | any merger or consolidation involving the corporation and the interested stockholder; |
• | any sale, transfer, pledge or other disposition of 10% or more of the assets of the corporation involving the interested stockholder; |
• | subject to certain exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder; |
• | any transaction involving the corporation that has the effect of increasing the proportionate share of the stock of any class or series of the corporation beneficially owned by the interested stockholder; or |
• | the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits provided by or through the corporation. |
* | The stock performance included in this graph is not necessarily indicative of future stock performance. |
Company/Index |
Base Period 12/30/2016 |
12/29/2017 | 12/31/2018 | 12/31/2019 | 12/31/2020 | 12/31/2021 | ||||||||||||||||||
Magnachip Semiconductor Corporation |
100 | 160.48 | 100.16 | 187.26 | 218.06 | 338.23 | ||||||||||||||||||
S&P 500 Index |
100 | 119.42 | 111.97 | 145.52 | 167.77 | 212.89 | ||||||||||||||||||
Philadelphia Semiconductor Index |
100 | 138.23 | 127.44 | 204.05 | 308.39 | 435.33 |
Period |
Total Number of Shares Purchased |
Average Price Paid per Share |
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(1) |
Approximate dollar value of Shares that may yet be Purchased under the Plans or Programs (in thousands)(1) |
||||||||||||
October 2021 |
— | — | — | — | ||||||||||||
November 2021 |
— | — | — | — | ||||||||||||
December 2021 |
994,695 | $ | 20.18 | 994,695 | $ | 54,927 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
994,695 | $ | 54,927 | |||||||||||||
|
|
|
|
|
|
|
|
(1) | On December 21, 2021, the Company’s Board of Directors authorized the Company to repurchase up to $75 million of the Company’s common stock. As an immediate step towards implementing the approved stock repurchase program, the Company entered into an accelerated stock repurchase agreement on December 21, 2021 with JPMorgan Chase Bank, National Association to repurchase an aggregate of $37.5 million of the Company’s common stock. |
• | we believe that Adjusted EBITDA, by eliminating the impact of a number of items that we do not consider to be indicative of our core ongoing operating performance, provides a more comparable measure of our operating performance from period-to-period |
• | we believe that Adjusted EBITDA is commonly requested and used by securities analysts, investors and other interested parties in the evaluation of a company as an enterprise level performance measure that eliminates the effects of financing, income taxes and the accounting effects of capital spending, as well as other one time or recurring items described above; and |
• | we believe that Adjusted EBITDA is useful for investors, among other reasons, to assess a company’s period-to-period |
• | for planning purposes, including the preparation of our annual operating budget; |
• | to evaluate the effectiveness of our enterprise level business strategies; |
• | in communications with our Board of Directors concerning our consolidated financial performance; and |
• | in certain of our compensation plans as a performance measure for determining incentive compensation payments. |
Year Ended December 31, 2021 |
Year Ended December 31, 2020 |
Year Ended December 31, 2019 |
||||||||||
(Dollars in millions) |
||||||||||||
Income (loss) from continuing operations |
$ | 56.7 | $ | 57.1 | $ | (20.4 | ) | |||||
Interest expense (income), net |
(1.2 | ) | 15.4 | 19.5 | ||||||||
Income tax expense (benefit) |
17.3 | (46.2 | ) | 2.2 | ||||||||
Depreciation and amortization |
14.2 | 11.1 | 10.3 | |||||||||
|
|
|
|
|
|
|||||||
EBITDA |
$ | 87.0 | $ | 37.4 | $ | 11.6 | ||||||
Adjustments: |
||||||||||||
Equity-based compensation expense(a) |
7.7 | 6.3 | 6.1 | |||||||||
Foreign currency loss, net(b) |
11.9 | 0.4 | 22.3 | |||||||||
Derivative valuation loss (gain), net(c) |
(0.1 | ) | (0.1 | ) | 0.3 | |||||||
Loss on early extinguishment of borrowings, net(d) |
— | 0.8 | 0.0 | |||||||||
Inventory reserve related to Huawei impact of downstream trade restrictions(e) |
(1.5 | ) | 1.5 | — | ||||||||
Expenses related to Fab 3 power outage(f) |
— | 1.2 | — | |||||||||
Merger-related costs (income), net(g) |
(35.5 | ) | 0.7 | — | ||||||||
Early termination and other charges, net(h) |
1.3 | 5.0 | 0.6 | |||||||||
|
|
|
|
|
|
|||||||
Adjusted EBITDA |
$ | 70.7 | $ | 52.9 | $ | 40.9 | ||||||
|
|
|
|
|
|
(a) | This adjustment eliminates the impact of non-cash equity-based compensation expenses. Although we expect to incur non-cash equity-based compensation expenses in the future, these expenses do not generally require cash settlement, and, therefore, are not used by us to assess the profitability of our operations. We believe that analysts and investors will find it helpful to review our operating performance without the effects of these non-cash expenses as supplemental information. |
(b) | This adjustment mainly eliminates the impact of non-cash foreign currency translation associated with intercompany debt obligations and foreign currency denominated receivables and payables, as well as the cash impact of foreign currency transaction gains or losses on collection of such receivables and payment of such payables. Although we expect to incur foreign currency translation gains or losses in the future, we believe that analysts and investors will find it helpful to review our operating performance without the effects of these primarily non-cash gains or losses, which we cannot control. Additionally, we believe the isolation of this adjustment provides investors with enhanced comparability to prior and future periods of our operating performance results. |
(c) | This adjustment eliminates the impact of gain or loss recognized in income on derivatives, which represents derivatives value changes excluded from the risk being hedged. We enter into derivative transactions to mitigate foreign exchange risks. As our derivative transactions are limited to a certain portion of our expected cash flows denominated in U.S. dollars, and we do not enter into derivative transactions for trading or speculative purposes, we do not believe that these charges or gains are indicative of our core operating performance. |
(d) | For the year ended December 31, 2020, this adjustment eliminates $0.8 million in expenses related to the full redemption of our outstanding 2021 Notes in the fourth quarter of 2020. For the year ended December 31, 2019, this adjustment eliminates expenses related to the repurchase of a portion of the 2021 Notes and the Exchangeable Notes in the first quarter of 2019. |
(e) | For the year ended December 31, 2020, this adjustment eliminates the impact of excess and obsolete inventory charge that we recorded in relation to the U.S. Government’s export restrictions on Huawei, which is a downstream customer of some of our direct customers. For the year ended December 31, 2021, this adjustment eliminates a reversal of such inventory charge as such reserved inventory was subsequently sold to certain other customers. As this charge and the timing of its reversal meaningfully impacted our operational results and are not expected to represent an ongoing operating expense subject to our ability to foresee and control, we believe our operating performance results are more meaningfully compared if this charge and related reversal are excluded. |
(f) | This adjustment eliminates $1.2 million in expenses related to the write-off of the damaged work in process wafers and charges for facility recovery. These charges are inconsistent in amount and frequency, and we do not believe that these charges are indicative of our core operation performance and have been excluded for comparative purposes. |
(g) | For the year ended December 31, 2021, this adjustment eliminates $70.2 million income from the recognition of termination fee from the Parent as a result of the termination of the merger transaction. For the years ended December 31, 2021 and 2020, respectively, this adjustment eliminates non-recurring professional service fees and expenses of $34.7 million and $0.7 million, incurred in connection with the contemplated merger transaction. As these adjustments meaningfully impacted our operating results and are not expected to represent an ongoing operating expense or income to us, we believe our operating performance results are more usefully compared if these adjustments are excluded. |
(h) | For the year ended December 31, 2021, this adjustment eliminates $3.4 million non-recurring professional service fees and expenses incurred in connection with the regulatory requests, which was offset in part by $1.4 million gain on sale of certain legacy equipment of the closed back-end line in our fabrication facility in Gumi (which was closed during the year ended December 31, 2018), and $0.7 million legal settlement gain related to certain expenses incurred in prior periods in connection with our legacy Fab 4 (which was sold during the year ended December 31, 2020) and awarded in the third quarter of 2021. For the year ended December 31, 2020, this adjustment eliminates $4.4 million of charges related to the reduction of workforce under the Program and $0.6 million of non-recurring professional service fees and expenses incurred in connection with certain treasury and finance initiatives. For the year ended December 31, 2019, this adjustment primarily eliminates a $0.5 million legal settlement charge related to dispute with a prior customer and a legal expense related to the indemnification of a former employee during the three months ended March 31, 2019. As these adjustments meaningfully impacted our operating results and are not expected to represent an ongoing operating expense or income to us, we believe our operating performance results are more usefully compared if these adjustments are excluded. |
• | Adjusted EBITDA does not reflect our cash expenditures, or future requirements, for capital expenditures or contractual commitments; |
• | Adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs; |
• | Adjusted EBITDA does not reflect the interest expense, or the cash requirements necessary to service interest or principal payments, on our debt; |
• | although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often need to be replaced in the future, and Adjusted EBITDA does not reflect any cash requirements for such replacements; |
• | Adjusted EBITDA does not consider the potentially dilutive impact of issuing equity-based compensation to our management team and employees; |
• | Adjusted EBITDA does not reflect the costs of holding certain assets and liabilities in foreign currencies; and |
• | other companies in our industry may calculate Adjusted EBITDA differently than we do, limiting its usefulness as a comparative measure. |
Year Ended December 31, 2021 |
Year Ended December 31, 2020 |
Year Ended December 31, 2019 |
||||||||||
(Dollars in millions) |
||||||||||||
Operating income |
$ | 83.4 | $ | 27.0 | $ | 23.7 | ||||||
Adjustments: |
||||||||||||
Equity-based compensation expense(a) |
7.7 | 6.3 | 6.1 | |||||||||
Inventory reserve related to Huawei impact of downstream trade restrictions(b) |
(1.5 | ) | 1.5 | — | ||||||||
Expenses related to Fab 3 power outage(c) |
— | 1.2 | — | |||||||||
Merger-related costs (income), net(d) |
(35.5 | ) | 0.7 | — | ||||||||
Early termination and other charges(e) |
2.0 | 5.0 | 0.6 | |||||||||
|
|
|
|
|
|
|||||||
Adjusted Operating Income |
$ | 56.1 | $ | 41.6 | $ | 30.4 | ||||||
|
|
|
|
|
|
(a) | This adjustment eliminates the impact of non-cash equity-based compensation expenses. Although we expect to incur non-cash equity-based compensation expenses in the future, these expenses do not generally require cash settlement, and, therefore, are not used by us to assess the profitability of our operations. We believe that analysts and investors will find it helpful to review our operating performance without the effects of these non-cash expenses as supplemental information. |
(b) | For the year ended December 31, 2020, this adjustment eliminates the impact of excess and obsolete inventory charge that we recorded in relation to the U.S. Government’s export restrictions on Huawei, which is a downstream customer of some of our direct customers. For the year ended December 31, 2021, this adjustment eliminates a reversal of such inventory charge as such reserved inventory was subsequently sold to certain other customers. As this charge and the timing of its reversal meaningfully impacted our operational results and are not expected to represent an ongoing operating expense subject to our ability to foresee and control, we believe our operating performance results are more meaningfully compared if this charge and related reversal are excluded. |
(c) | This adjustment eliminates $1.2 million in expenses related to the write-off of the damaged work in process wafers and charges for facility recovery. These charges are inconsistent in amount and frequency, and we do not believe that these charges are indicative of our core operation performance and have been excluded for comparative purposes. |
(d) | For the year ended December 31, 2021, this adjustment eliminates $70.2 million income from the recognition of termination fee from the Parent as a result of the termination of the merger transaction. For the years ended December 31, 2021 and 2020, respectively, this adjustment eliminates non-recurring professional service fees and expenses of $34.7 million and $0.7 million, incurred in connection with the contemplated merger transaction. As these adjustments meaningfully impacted our operating results and are not expected to represent an ongoing operating expense or income to us, we believe our operating performance results are more usefully compared if these adjustments are excluded. |
(e) | For the year ended December 31, 2021, this adjustment eliminates $3.4 million non-recurring professional service fees and expenses incurred in connection with the regulatory requests, which was offset in part by $1.4 million gain on sale of certain legacy equipment of the closed back-end line in our fabrication facility in Gumi (which was closed during the year ended December 31, 2018). For the year ended December 31, 2020, this adjustment eliminates $4.4 million of charges related to the reduction of workforce under the Program and $0.6 million of non-recurring professional service fees and expenses incurred in connection with certain treasury and finance initiatives. For the year ended December 31, 2019, this adjustment primarily eliminates a $0.5 million legal settlement charge related to dispute with a prior customer and a legal expense related to the indemnification of a former employee during the three months ended March 31, 2019. As these adjustments meaningfully impacted our operating results and are not expected to represent an ongoing operating expense or income to us, we believe our operating performance results are more usefully compared if these adjustments are excluded. |
• | we use Adjusted Net Income (including on a per share basis) in communications with our Board of Directors concerning our consolidated financial performance without the impact of non-cash expenses and the other items as we discussed below since we believe that it is a more consistent measure of our core operating results from period to period; and |
• | we believe that reporting Adjusted Net Income (including on a per share basis) is useful to readers in evaluating our core operating results because it eliminates the effects of non-cash expenses as well as the other items we discuss below, such as foreign currency gains and losses, which are out of our control and can vary significantly from period to period. |
Year Ended December 31, 2021 |
Year Ended December 31, 2020 |
Year Ended December 31, 2019 |
||||||||||
(Dollars in millions, except per share data) |
||||||||||||
Income (loss) from continuing operations |
$ | 56.7 | $ | 57.1 | $ | (20.4 | ) | |||||
Adjustments: |
||||||||||||
Equity-based compensation expense(a) |
7.7 | 6.3 | 6.1 | |||||||||
Foreign currency loss, net(b) |
11.9 | 0.4 | 22.3 | |||||||||
Derivative valuation loss (gain), net(c) |
(0.1 | ) | (0.1 | ) | 0.3 | |||||||
Loss on early extinguishment of borrowings, net(d) |
— | 0.8 | 0.0 | |||||||||
Inventory reserve related to Huawei impact of downstream trade restrictions(e) |
(1.5 | ) | 1.5 | — | ||||||||
Expenses related to Fab 3 power outage(f) |
— | 1.2 | — | |||||||||
Merger-related costs (income), net(g) |
(35.5 | ) | 0.7 | — | ||||||||
Early termination and other charges, net(h) |
1.3 | 5.0 | 0.6 | |||||||||
GAAP and cash tax expense difference(i) |
0.9 | (43.9 | ) | — | ||||||||
Income tax effect on non-GAAP adjustments(j) |
9.7 | (0.5 | ) | — | ||||||||
|
|
|
|
|
|
|||||||
Adjusted Net Income |
$ | 51.1 | $ | 28.3 | $ | 9.0 | ||||||
|
|
|
|
|
|
|||||||
Reported earnings (loss) per share—basic |
$ | 1.26 | $ | 1.62 | $ | (0.59 | ) | |||||
Reported earnings (loss) per share—diluted |
$ | 1.21 | $ | 1.35 | $ | (0.59 | ) | |||||
Weighted average number of shares—basic |
44,879,412 | 35,213,525 | 34,321,888 | |||||||||
Weighted average number of shares—diluted |
47,709,373 | 46,503,586 | 34,321,888 | |||||||||
Adjusted earnings per share—basic |
$ | 1.14 | $ | 0.80 | $ | 0.26 | ||||||
Adjusted earnings per share—diluted |
$ | 1.09 | $ | 0.73 | $ | 0.25 | ||||||
Weighted average number of shares—basic |
44,879,412 | 35,213,525 | 34,321,888 | |||||||||
Weighted average number of shares—diluted |
47,709,373 | 46,503,586 | 35,405,077 |
(a) | This adjustment eliminates the impact of non-cash equity-based compensation expenses. Although we expect to incur non-cash equity-based compensation expenses in the future, these expenses do not generally require cash settlement, and, therefore, are not used by us to assess the profitability of our operations. We believe that analysts and investors will find it helpful to review our operating performance without the effects of these non-cash expenses as supplemental information. |
(b) | This adjustment mainly eliminates the impact of non-cash foreign currency translation associated with intercompany debt obligations and foreign currency denominated receivables and payables, as well as the cash impact of foreign currency transaction gains or losses on collection of such receivables and payment of such payables. Although we expect to incur foreign currency translation gains or losses in the future, we believe that analysts and investors will find it helpful to review our operating performance without the effects of these primarily non-cash gains or losses, which we cannot control. Additionally, we believe the isolation of this adjustment provides investors with enhanced comparability to prior and future periods of our operating performance results. |
(c) | This adjustment eliminates the impact of gain or loss recognized in income on derivatives, which represents derivatives value changes excluded from the risk being hedged. We enter into derivative transactions to mitigate foreign exchange risks. As our derivative transactions are limited to a certain portion of our |
expected cash flows denominated in U.S. dollars, and we do not enter into derivative transactions for trading or speculative purposes, we do not believe that these charges or gains are indicative of our core operating performance. |
(d) | For the year ended December 31, 2020, this adjustment eliminates $0.8 million in expenses related to the full redemption of our outstanding 2021 Notes in the fourth quarter of 2020. For the year ended December 31, 2019, this adjustment eliminates expenses related to the repurchase of a portion of the 2021 Notes and the Exchangeable Notes in the first quarter of 2019. |
(e) | For the year ended December 31, 2020, this adjustment eliminates the impact of excess and obsolete inventory charge that we recorded in relation to the U.S. Government’s export restrictions on Huawei, which is a downstream customer of some of our direct customers. For the year ended December 31, 2021, this adjustment eliminates a reversal of such inventory charge as such reserved inventory was subsequently sold to certain other customers. As this charge and the timing of its reversal meaningfully impacted our operational results and are not expected to represent an ongoing operating expense subject to our ability to foresee and control, we believe our operating performance results are more meaningfully compared if this charge and related reversal are excluded. |
(f) | This adjustment eliminates $1.2 million in expenses related to the write-off of the damaged work in process wafers and charges for facility recovery. These charges are inconsistent in amount and frequency, and we do not believe that these charges are indicative of our core operation performance and have been excluded for comparative purposes. |
(g) | For the year ended December 31, 2021, this adjustment eliminates $70.2 million income from the recognition of termination fee from the Parent as a result of the termination of the merger transaction. For the years ended December 31, 2021 and 2020, respectively, this adjustment eliminates non-recurring professional service fees and expenses of $34.7 million and $0.7 million, incurred in connection with the contemplated merger transaction. As these adjustments meaningfully impacted our operating results and are not expected to represent an ongoing operating expense or income to us, we believe our operating performance results are more usefully compared if these adjustments are excluded. |
(h) | For the year ended December 31, 2021, this adjustment eliminates $3.4 million non-recurring professional service fees and expenses incurred in connection with the regulatory requests, which was offset in part by $1.4 million gain on sale of certain legacy equipment of the closed back-end line in our fabrication facility in Gumi (which was closed during the year ended December 31, 2018), and $0.7 million legal settlement gain related to certain expenses incurred in prior periods in connection with our legacy Fab 4 (which was sold during the year ended December 31, 2020) and awarded in the third quarter of 2021. For the year ended December 31, 2020, this adjustment eliminates $4.4 million of charges related to the reduction of workforce under the Program and $0.6 million of non-recurring professional service fees and expenses incurred in connection with certain treasury and finance initiatives. For the year ended December 31, 2019, this adjustment primarily eliminates a $0.5 million legal settlement charge related to dispute with a prior customer and a legal expense related to the indemnification of a former employee during the three months ended March 31, 2019. As these adjustments meaningfully impacted our operating results and are not expected to represent an ongoing operating expense or income to us, we believe our operating performance results are more usefully compared if these adjustments are excluded. |
(i) | This adjustment eliminates the impact of difference between GAAP and cash tax expense. |
(j) | For the years ended December 31, 2021 and 2020, income tax effect on non-GAAP adjustments were calculated by calculating the tax expense of each jurisdiction with or without the non-GAAP adjustments. For the year ended December 31, 2021, income tax effect on non-GAAP adjustments related to our Korean subsidiary and the U.S parent entity were $2.8 million and $6.9 million, respectively. For the year ended December 31, 2020, income tax effect on non-GAAP adjustments related to our Korean subsidiary was $0.5 million. For the year ended December 31, 2019, there was no tax impact from the adjustments to net income (loss) from continuing operations to calculate our Adjusted Net Income due to net operating loss carry-forwards available to offset taxable income and full allowance for deferred tax assets. |
• | Adjusted Net Income does not reflect changes in, or cash requirements for, our working capital needs; |
• | Adjusted Net Income does not consider the potentially dilutive impact of issuing equity-based compensation to our management team and employees; |
• | Adjusted Net Income does not reflect the costs of holding certain assets and liabilities in foreign currencies; and |
• | other companies in our industry may calculate Adjusted Net Income differently than we do, limiting its usefulness as a comparative measure. |
Year Ended December 31, 2021 |
Year Ended December 31, 2020 |
Year Ended December 31, 2019 |
||||||||||||||||||||||
Amount |
% of Total revenues |
Amount |
% of Total revenues |
Amount |
% of Total revenues |
|||||||||||||||||||
(Dollars in millions) |
||||||||||||||||||||||||
Consolidated statements of operations data: |
||||||||||||||||||||||||
Revenues |
||||||||||||||||||||||||
Net sales—standard products business |
$ | 433.1 | 91.3 | % | $ | 465.5 | 91.8 | % | $ | 484.8 | 93.1 | % | ||||||||||||
Net sales—transitional Fab 3 foundry services |
41.1 | 8.7 | 41.5 | 8.2 | 35.8 | 6.9 | ||||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||
Total revenues |
474.2 | 100.0 | 507.1 | 100.0 | 520.7 | 100.0 | ||||||||||||||||||
Cost of sales |
||||||||||||||||||||||||
Cost of sales—standard products business |
283.5 | 59.8 | 338.4 | 66.7 | 368.5 | 70.8 | ||||||||||||||||||
Cost of sales—transitional Fab 3 foundry services |
37.2 | 7.8 | 40.3 | 8.0 | 35.8 | 6.9 | ||||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||
Total cost of sales |
320.7 | 67.6 | 378.7 | 74.7 | 404.3 | 77.6 | ||||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||
Gross profit |
153.5 | 32.4 | 128.3 | 25.3 | 116.4 | 22.4 | ||||||||||||||||||
Selling, general and administrative expenses |
52.4 | 11.1 | 50.0 | 9.9 | 47.6 | 9.1 | ||||||||||||||||||
Research and development expenses |
51.2 | 10.8 | 45.7 | 9.0 | 45.0 | 8.6 | ||||||||||||||||||
Merger-related costs (income), net |
(35.5 | ) | (7.5 | ) | 0.7 | 0.1 | — | — | ||||||||||||||||
Early termination and other charges, net |
2.0 | 0.4 | 5.0 | 1.0 | 0.1 | 0.0 | ||||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||
Operating income |
83.4 | 17.6 | 27.0 | 5.3 | 23.7 | 4.6 | ||||||||||||||||||
Interest expense |
(1.4 | ) | (0.3 | ) | (18.1 | ) | (3.6 | ) | (22.2 | ) | (4.3 | ) | ||||||||||||
Foreign currency loss, net |
(11.9 | ) | (2.5 | ) | (0.4 | ) | (0.1 | ) | (22.3 | ) | (4.3 | ) | ||||||||||||
Loss on early extinguishment of borrowings, net |
— | — | (0.8 | ) | (0.2 | ) | (0.0 | ) | (0.0 | ) | ||||||||||||||
Others, net |
3.8 | 0.8 | 3.1 | 0.6 | 2.6 | 0.5 | ||||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||
(9.4 | ) | (2.0 | ) | (16.2 | ) | (3.2 | ) | (41.9 | ) | (8.1 | ) | |||||||||||||
|
|
|
|
|
|
|||||||||||||||||||
Income (loss) from continuing operations before income tax expense |
74.0 | 15.6 | 10.8 | 2.1 | (18.2 | ) | (3.5 | ) | ||||||||||||||||
Income tax expense (benefit) |
17.3 | 3.6 | (46.2 | ) | (9.1 | ) | 2.2 | 0.4 | ||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||
Income (loss) from continuing operations |
56.7 | 12.0 | 57.1 | 11.3 | (20.4 | ) | (3.9 | ) | ||||||||||||||||
Income (loss) from discontinued operations, net of tax |
— | — | 287.9 | 56.8 | (1.4 | ) | (0.3 | ) | ||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||
Net income (loss) |
$ | 56.7 | 12.0 | % | $ | 345.0 | 68.0 | % | $ | (21.8 | ) | (4.2 | )% | |||||||||||
|
|
|
|
|
|
|||||||||||||||||||
Revenues: |
||||||||||||||||||||||||
Net sales—standard products business |
||||||||||||||||||||||||
Display Solutions |
205.3 | 43.3 | 299.1 | 59.0 | 308.5 | 59.3 | ||||||||||||||||||
Power Solutions |
227.8 | 48.0 | 166.5 | 32.8 | 176.3 | 33.9 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total standard products business |
433.1 | 91.3 | 465.5 | 91.8 | 484.8 | 93.1 | ||||||||||||||||||
Net sales—transitional Fab 3 foundry services |
41.1 | 8.7 | 41.5 | 8.2 | 35.8 | 6.9 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total revenues |
$ | 474.2 | 100.0 | % | $ | 507.1 | 100.0 | % | $ | 520.7 | 100.0 | % | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2021 |
Year Ended December 31, 2020 |
|||||||||||||||||||
Amount |
% of Total revenues |
Amount |
% of Total revenues |
Change Amount |
||||||||||||||||
(Dollars in millions) |
||||||||||||||||||||
Revenues |
||||||||||||||||||||
Net sales—standard products business |
$ | 433.1 | 91.3 | % | $ | 465.5 | 91.8 | % | $ | (32.4 | ) | |||||||||
Net sales—transitional Fab 3 foundry services |
41.1 | 8.7 | 41.5 | 8.2 | (0.4 | ) | ||||||||||||||
|
|
|
|
|
|
|||||||||||||||
Total revenues |
474.2 | 100.0 | 507.1 | 100.0 | (32.8 | ) | ||||||||||||||
Cost of sales |
||||||||||||||||||||
Cost of sales—standard products business |
283.5 | 59.8 | 338.4 | 66.7 | (54.9 | ) | ||||||||||||||
Cost of sales—transitional Fab 3 foundry services |
37.2 | 7.8 | 40.3 | 8.0 | (3.1 | ) | ||||||||||||||
|
|
|
|
|
|
|||||||||||||||
Total cost of sales |
320.7 | 67.6 | 378.7 | 74.7 | (58.1 | ) | ||||||||||||||
|
|
|
|
|
|
|||||||||||||||
Gross profit |
153.5 | 32.4 | 128.3 | 25.3 | 25.2 | |||||||||||||||
Selling, general and administrative expenses |
52.4 | 11.1 | 50.0 | 9.9 | 2.5 | |||||||||||||||
Research and development expenses |
51.2 | 10.8 | 45.7 | 9.0 | 5.5 | |||||||||||||||
Merger-related costs (income), net |
(35.5 | ) | (7.5 | ) | 0.7 | 0.1 | (36.2 | ) | ||||||||||||
Early termination and other charges, net |
2.0 | 0.4 | 5.0 | 1.0 | (3.0 | ) | ||||||||||||||
|
|
|
|
|
|
|||||||||||||||
Operating income |
83.4 | 17.6 | 27.0 | 5.3 | 56.4 | |||||||||||||||
Interest expense |
(1.4 | ) | (0.3 | ) | (18.1 | ) | (3.6 | ) | 16.8 | |||||||||||
Foreign currency loss, net |
(11.9 | ) | (2.5 | ) | (0.4 | ) | (0.1 | ) | (11.5 | ) | ||||||||||
Loss on early extinguishment of borrowings, net |
— | — | (0.8 | ) | (0.2 | ) | 0.8 | |||||||||||||
Others, net |
3.8 | 0.8 | 3.1 | 0.6 | 0.7 | |||||||||||||||
|
|
|
|
|
|
|||||||||||||||
(9.4 | ) | (2.0 | ) | (16.2 | ) | (3.2 | ) | 6.7 | ||||||||||||
|
|
|
|
|
|
|||||||||||||||
Income from continuing operations before income tax expense |
74.0 | 15.6 | 10.8 | 2.1 | 63.1 | |||||||||||||||
Income tax expense (benefit) |
17.3 | 3.6 | (46.2 | ) | (9.1 | ) | 63.5 | |||||||||||||
|
|
|
|
|
|
|||||||||||||||
Income from continuing operations |
56.7 | 12.0 | 57.1 | 11.3 | (0.4 | ) | ||||||||||||||
Income from discontinued operations, net of tax |
— | — | 287.9 | 56.8 | (287.9 | ) | ||||||||||||||
|
|
|
|
|
|
|||||||||||||||
Net income |
$ | 56.7 | 12.0 | % | $ | 345.0 | 68.0 | % | $ | (288.3 | ) | |||||||||
|
|
|
|
|
|
Year Ended December 31, 2021 |
Year Ended December 31, 2020 |
|||||||||||||||||||
Amount |
% of Total revenues |
Amount |
% of Total revenues |
Change Amount |
||||||||||||||||
(Dollars in millions) |
||||||||||||||||||||
Revenues |
||||||||||||||||||||
Net sales—standard products business |
||||||||||||||||||||
Display Solutions |
205.3 | 43.3 | 299.1 | 59.0 | (93.7 | ) | ||||||||||||||
Power Solutions |
227.8 | 48.0 | 166.5 | 32.8 | 61.3 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total standard products business |
433.1 | 91.3 | 465.5 | 91.8 | (32.4 | ) | ||||||||||||||
Net sales—transitional Fab 3 foundry services |
41.1 | 8.7 | 41.5 | 8.2 | (0.4 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total revenues |
$ | 474.2 | 100.0 | % | $ | 507.1 | 100.0 | % | $ | (32.8 | ) | |||||||||
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2021 |
Year Ended December 31, 2020 |
|||||||||||||||||||
Amount |
% of Net Sales |
Amount |
% of Net Sales |
Change Amount |
||||||||||||||||
(Dollars in millions) |
||||||||||||||||||||
Gross Profit |
||||||||||||||||||||
Gross profit—standard products business |
149.6 | 34.5 | 127.1 | 27.3 | 22.5 | |||||||||||||||
Gross profit—transitional Fab 3 foundry services |
3.9 | 9.6 | 1.2 | 2.9 | 2.7 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total gross profit |
$ | 153.5 | 32.4 | % | $ | 128.3 | 25.3 | % | $ | 25.2 | ||||||||||
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2021 |
Year Ended December 31, 2020 |
|||||||||||||||||||
Amount |
% of Net Sales – standard products business |
Amount |
% of Net Sales – standard products business |
Change Amount |
||||||||||||||||
(Dollars in millions) |
||||||||||||||||||||
Korea |
$ | 113.8 | 26.3 | % | $ | 106.4 | 22.9 | % | $ | 7.4 | ||||||||||
Asia Pacific (other than Korea) |
306.3 | 70.7 | 347.6 | 74.7 | (41.3 | ) | ||||||||||||||
United States |
6.1 | 1.4 | 5.1 | 1.1 | 0.9 | |||||||||||||||
Europe |
5.7 | 1.3 | 4.3 | 0.9 | 1.4 | |||||||||||||||
Others |
1.2 | 0.3 | 2.0 | 0.4 | (0.8 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 433.1 | 100.0 | % | $ | 465.5 | 100.0 | % | $ | (32.4 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2020 |
Year Ended December 31, 2019 |
|||||||||||||||||||
Amount |
% of Total revenues |
Amount |
% of Total revenues |
Change Amount |
||||||||||||||||
(Dollars in millions) |
||||||||||||||||||||
Revenues |
||||||||||||||||||||
Net sales—standard products business |
$ | 465.5 | 91.8 | % | $ | 484.8 | 93.1 | % | $ | (19.3 | ) | |||||||||
Net sales—transitional Fab 3 foundry services |
41.5 | 8.2 | 35.8 | 6.9 | 5.7 | |||||||||||||||
|
|
|
|
|
|
|||||||||||||||
Total revenues |
507.1 | 100.0 | 520.7 | 100.0 | (13.6 | ) | ||||||||||||||
Cost of sales |
||||||||||||||||||||
Cost of sales—standard products business |
338.4 | 66.7 | 368.5 | 70.8 | (30.0 | ) | ||||||||||||||
Cost of sales—transitional Fab 3 foundry services |
40.3 | 8.0 | 35.8 | 6.9 | 4.5 | |||||||||||||||
|
|
|
|
|
|
|||||||||||||||
Total cost of sales |
378.7 | 74.7 | 404.3 | 77.6 | (25.5 | ) | ||||||||||||||
|
|
|
|
|
|
|||||||||||||||
Gross profit |
128.3 | 25.3 | 116.4 | 22.4 | 11.9 | |||||||||||||||
Selling, general and administrative expenses |
50.0 | 9.9 | 47.6 | 9.1 | 2.4 | |||||||||||||||
Research and development expenses |
45.7 | 9.0 | 45.0 | 8.6 | 0.7 | |||||||||||||||
Merger-related costs |
0.7 | 0.1 | — | — | 0.7 | |||||||||||||||
Early termination and other charges |
5.0 | 1.0 | 0.1 | 0.0 | 4.9 | |||||||||||||||
|
|
|
|
|
|
|||||||||||||||
Operating income |
27.0 | 5.3 | 23.7 | 4.6 | 3.3 | |||||||||||||||
Interest expense |
(18.1 | ) | (3.6 | ) | (22.2 | ) | (4.3 | ) | 4.0 | |||||||||||
Foreign currency loss, net |
(0.4 | ) | (0.1 | ) | (22.3 | ) | (4.3 | ) | 21.9 | |||||||||||
Loss on early extinguishment of borrowings, net |
(0.8 | ) | (0.2 | ) | (0.0 | ) | (0.0 | ) | (0.7 | ) | ||||||||||
Others, net |
3.1 | 0.6 | 2.6 | 0.5 | 0.5 | |||||||||||||||
|
|
|
|
|
|
|||||||||||||||
(16.2 | ) | (3.2 | ) | (41.9 | ) | (8.1 | ) | 25.8 | ||||||||||||
|
|
|
|
|
|
|||||||||||||||
Income (loss) from continuing operations before income tax expense |
10.8 | 2.1 | (18.2 | ) | (3.5 | ) | 29.0 | |||||||||||||
Income tax expense (benefit) |
(46.2 | ) | (9.1 | ) | 2.2 | 0.4 | (48.4 | ) | ||||||||||||
|
|
|
|
|
|
|||||||||||||||
Income (loss) from continuing operations |
57.1 | 11.3 | (20.4 | ) | (3.9 | ) | 77.5 | |||||||||||||
Income (loss) from discontinued operations, net of tax |
287.9 | 56.8 | (1.4 | ) | (0.3 | ) | 289.3 | |||||||||||||
|
|
|
|
|
|
|||||||||||||||
Net income (loss) |
$ | 345.0 | 68.0 | % | $ | (21.8 | ) | (4.2 | )% | $ | 366.8 | |||||||||
|
|
|
|
|
|
Year Ended December 31, 2020 |
Year Ended December 31, 2019 |
|||||||||||||||||||
Amount |
% of Total revenues |
Amount |
% of Total revenues |
Change Amount |
||||||||||||||||
(Dollars in millions) |
||||||||||||||||||||
Revenues |
||||||||||||||||||||
Net sales—standard products business |
||||||||||||||||||||
Display Solutions |
299.1 | 59.0 | 308.5 | 59.3 | (9.5 | ) | ||||||||||||||
Power Solutions |
166.5 | 32.8 | 176.3 | 33.9 | (9.9 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total standard products business |
465.5 | 91.8 | 484.8 | 93.1 | (19.3 | ) | ||||||||||||||
Net sales—transitional Fab 3 foundry services |
41.5 | 8.2 | 35.8 | 6.9 | 5.7 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total revenues |
$ | 507.1 | 100.0 | % | $ | 520.7 | 100.0 | % | $ | (13.6 | ) | |||||||||
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2020 |
Year Ended December 31, 2019 |
|||||||||||||||||||
Amount |
% of Net Sales |
Amount |
% of Net Sales |
Change Amount |
||||||||||||||||
(Dollars in millions) |
||||||||||||||||||||
Gross Profit |
||||||||||||||||||||
Gross profit—standard products business |
127.1 | 27.3 | 116.4 | 24.0 | 10.7 | |||||||||||||||
Gross profit—transitional Fab 3 foundry services |
1.2 | 2.9 | — | — | 1.2 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total gross profit |
$ | 128.3 | 25.3 | % | $ | 116.4 | 22.4 | % | $ | 11.9 | ||||||||||
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2020 |
Year Ended December 31, 2019 |
|||||||||||||||||||
Amount |
% of Net Sales – standard products business |
Amount |
% of Net Sales – standard products business |
Change Amount |
||||||||||||||||
(Dollars in millions) |
||||||||||||||||||||
Korea |
$ | 106.4 | 22.9 | % | $ | 132.6 | 27.4 | % | $ | (26.2 | ) | |||||||||
Asia Pacific (other than Korea) |
347.6 | 74.7 | 343.7 | 70.9 | 3.9 | |||||||||||||||
United States |
5.1 | 1.1 | 2.4 | 0.5 | 2.7 | |||||||||||||||
Europe |
4.3 | 0.9 | 4.8 | 1.0 | (0.5 | ) | ||||||||||||||
Others |
2.0 | 0.4 | 1.4 | 0.3 | 0.7 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 465.5 | 100.0 | % | $ | 484.8 | 100.0 | % | $ | (19.3 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
77 |
||||
80 |
||||
81 |
||||
82 |
||||
83 |
||||
84 |
||||
85 |
/s/ |
February 23, 2022 |
December 31, |
||||||||
2021 |
2020 |
|||||||
(In thousands of U.S. dollars, except share data) |
||||||||
Assets |
||||||||
Current assets |
||||||||
Cash and cash equivalents |
$ |
$ |
||||||
Accounts receivable, net |
||||||||
Inventories, net |
||||||||
Other receivables (Note 19) |
||||||||
Prepaid expenses |
||||||||
Hedge collateral (Note 10) |
||||||||
Other current assets |
||||||||
Total current assets |
||||||||
Property, plant and equipment, net |
||||||||
Operating lease right-of-use |
||||||||
Intangible assets, net |
||||||||
Long-term prepaid expenses |
||||||||
Deferred income taxes (Note 17) |
||||||||
Other non-current assets |
||||||||
Total assets |
$ |
$ |
||||||
Liabilities and Stockholders’ Equity |
||||||||
Current liabilities |
||||||||
Accounts payable |
$ |
$ |
||||||
Other accounts payable |
||||||||
Accrued expenses (Note 9) |
||||||||
Accrued income taxes |
||||||||
Operating lease liabilities |
||||||||
Current portion of long-term borrowings, net |
— |
|||||||
Other current liabilities |
||||||||
Total current liabilities |
||||||||
Accrued severance benefits, net |
||||||||
Non-current operating lease liabilities |
||||||||
Other non-current liabilities |
||||||||
Total liabilities |
||||||||
Commitments and contingencies (Note 20 ) |
||||||||
Stockholders’ equity |
||||||||
Common stock, par shares shares outstanding December 31, 2021 and shares issued and outstanding at December 31, 2020 |
||||||||
Additional paid-in capital |
||||||||
Retained earnings |
||||||||
Treasury stock, shares at December 31, 2021 and shares at December 31, 2020, respectively |
( |
) |
( |
) | ||||
Accumulated other comprehensive income (loss) |
( |
) |
||||||
Total stockholders’ equity |
||||||||
Total liabilities and stockholders’ equity |
$ |
$ |
||||||
Year Ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
(In thousands of U.S. dollars, except share data) |
||||||||||||
Revenues: |
||||||||||||
Net sales—standard products business |
$ | $ | $ | |||||||||
Net sales—transitional Fab 3 foundry services |
||||||||||||
|
|
|
|
|
|
|||||||
Total revenues |
||||||||||||
Cost of sales: |
||||||||||||
Cost of sales—standard products business |
||||||||||||
Cost of sales—transitional Fab 3 foundry services |
||||||||||||
|
|
|
|
|
|
|||||||
Total cost of sales |
||||||||||||
|
|
|
|
|
|
|||||||
Gross profit |
||||||||||||
Operating expenses: |
||||||||||||
Selling, general and administrative expenses |
||||||||||||
Research and development expenses |
||||||||||||
Merger-related costs (income), net |
( |
) | — | |||||||||
Early termination and other charges, net |
||||||||||||
|
|
|
|
|
|
|||||||
Total operating expenses |
||||||||||||
|
|
|
|
|
|
|||||||
Operating income: |
||||||||||||
Interest expense |
( |
) | ( |
) | ( |
) | ||||||
Foreign currency loss, net |
( |
) | ( |
) | ( |
) | ||||||
Loss on early extinguishment of borrowings, net |
( |
) | ( |
) | ||||||||
Other income, net |
||||||||||||
|
|
|
|
|
|
|||||||
Income (loss) from continuing operations before income tax expense |
( |
) | ||||||||||
Income tax expense (benefit) |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Income (loss) from continuing operations |
( |
) | ||||||||||
Income (loss) from discontinued operations, net of tax |
— | ( |
) | |||||||||
|
|
|
|
|
|
|||||||
Net income (loss) |
$ | $ | $ | ( |
) | |||||||
|
|
|
|
|
|
|||||||
Basic earnings (loss) per common share— |
||||||||||||
Continuing operations |
$ | $ | $ | ( |
) | |||||||
Discontinued operations |
— | ( |
) | |||||||||
|
|
|
|
|
|
|||||||
Total |
$ | $ | $ | ( |
) | |||||||
|
|
|
|
|
|
|||||||
Diluted earnings (loss) per common share— |
||||||||||||
Continuing operations |
$ | $ | $ | ( |
) | |||||||
Discontinued operations |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Total |
$ | $ | $ | ( |
) | |||||||
|
|
|
|
|
|
|||||||
Weighted average number of shares— |
||||||||||||
Basic |
||||||||||||
Diluted |
Year Ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
(In thousands of U.S. dollars) |
||||||||||||
Net income (loss) |
$ | $ | $ | ( |
) | |||||||
|
|
|
|
|
|
|||||||
Other comprehensive income (loss) |
||||||||||||
Foreign currency translation adjustments |
( |
) | ||||||||||
Derivative adjustments |
||||||||||||
Fair valuation of derivatives |
( |
) | ( |
) | ||||||||
Reclassification adjustment for loss (gain) on derivatives included in net income (loss) |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Total other comprehensive income (loss) |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Total comprehensive income (loss) |
$ | $ | $ | ( |
) | |||||||
|
|
|
|
|
|
Common Stock |
Additional Paid-In Capital |
Retained Earnings (Deficit) |
Treasury Stock |
Accumulated Other Comprehensive Income (Loss) |
Total |
|||||||||||||||||||||||
(In thousands of U.S. dollars, except share data) |
Shares |
Amount |
||||||||||||||||||||||||||
Balance at December 31, 2018 |
$ | $ | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Stock-based compensation |
— | — | — | — | — | |||||||||||||||||||||||
Exercise of stock options |
— | — | — | |||||||||||||||||||||||||
Settlement of restricted stock units |
( |
) | — | — | — | — | ||||||||||||||||||||||
Acquisition of treasury stock |
( |
) | — | — | — | ( |
) | — | ( |
) | ||||||||||||||||||
Other comprehensive income, net |
— | — | — | — | — | |||||||||||||||||||||||
Net loss |
— | — | — | ( |
) | — | — | ( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance at December 31, 2019 |
$ | $ | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Stock-based compensation |
— | — | — | — | — | |||||||||||||||||||||||
Exercise of stock options |
— | — | — | |||||||||||||||||||||||||
Settlement of restricted stock units |
( |
) | — | — | — | — | ||||||||||||||||||||||
Acquisition of treasury stock |
( |
) | — | — | — | ( |
) | — | ( |
) | ||||||||||||||||||
Other comprehensive income, net |
— | — | — | — | — | |||||||||||||||||||||||
Net income |
— | — | — | — | — | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance at December 31, 2020 |
$ | $ | $ | $ | ( |
) | $ | $ | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Stock-based compensation |
— | — | — | — | — | |||||||||||||||||||||||
Exchange of exchangeable senior note |
— | — | — | |||||||||||||||||||||||||
Exercise of stock options |
— | — | — | |||||||||||||||||||||||||
Settlement of restricted stock units |
( |
) | — | — | — | — | ||||||||||||||||||||||
Accelerated stock repurchase |
( |
) | — | ( |
) | — | ( |
) | — | ( |
) | |||||||||||||||||
Acquisition of treasury stock |
( |
) | — | — | — | ( |
) | — | ( |
) | ||||||||||||||||||
Other comprehensive loss, net |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
Net income |
— | — | — | — | — | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance at December 31, 2021 |
$ | $ | $ | $ | ( |
) | $ | ( |
) | $ | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
(In thousands of U.S. dollars) |
||||||||||||
Cash flows from operating activities |
||||||||||||
Net income (loss) |
$ | $ | $ | ( |
) | |||||||
Adjustments to reconcile net income (loss) to net cash provided by operating activities |
||||||||||||
Depreciation and amortization |
||||||||||||
Provision for severance benefits |
||||||||||||
Amortization of debt issuance costs and original issue discount |
||||||||||||
Loss (gain) on foreign currency, net |
( |
) | ||||||||||
Provision for inventory reserves |
||||||||||||
Stock-based compensation |
||||||||||||
Loss on early extinguishment of borrowings, net |
— | |||||||||||
Gain on sale of discontinued operations |
— | ( |
) | — | ||||||||
Deferred income tax assets |
( |
) | ||||||||||
Other, net |
( |
) | ||||||||||
Changes in operating assets and liabilities |
||||||||||||
Accounts receivable, net |
( |
) | ( |
) | ||||||||
Unbilled accounts receivable, net |
— | |||||||||||
Inventories |
( |
) | ( |
) | ( |
) | ||||||
Other receivables |
( |
) | ( |
) | ||||||||
Other current assets |
||||||||||||
Accounts payable |
( |
) | ||||||||||
Other accounts payable |
( |
) | ( |
) | ( |
) | ||||||
Accrued expenses |
( |
) | ||||||||||
Accrued income taxes |
( |
) | ||||||||||
Deferred revenue |
( |
) | ( |
) | ||||||||
Other current liabilities |
( |
) | ||||||||||
Other non-current liabilities |
( |
) | ( |
) | ||||||||
Contributions to severance insurance deposit accounts |
( |
) | ( |
) | ( |
) | ||||||
Payment of severance benefits |
( |
) | ( |
) | ( |
) | ||||||
Other, net |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Net cash provided by operating activities |
||||||||||||
Cash flows from investing activities |
||||||||||||
Proceeds from settlement of hedge collateral |
||||||||||||
Payment of hedge collateral |
( |
) | ( |
) | ( |
) | ||||||
Proceeds from disposal of property, plant and equipment |
||||||||||||
Purchase of property, plant and equipment |
( |
) | ( |
) | ( |
) | ||||||
Payment for intellectual property registration |
( |
) | ( |
) | ( |
) | ||||||
Collection of guarantee deposits |
||||||||||||
Payment of guarantee deposits |
( |
) | ( |
) | ( |
) | ||||||
Proceeds from sale of discontinued operations |
— | — | ||||||||||
Other, net |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Net cash provided by (used in) investing activities |
( |
) | ( |
) | ||||||||
Cash flows from financing activities |
||||||||||||
Repayment of borrowings |
— | ( |
) | ( |
) | |||||||
Proceeds from exercise of stock options |
||||||||||||
Acquisition of treasury stock |
( |
) | ( |
) | ( |
) | ||||||
Acquisition of stock under accelerated stock repurchase agreement |
|
|
( |
) |
|
|
— |
|
|
|
— |
|
Payment under accelerated stock repurchase agreement |
( |
) | — | — | ||||||||
Repayment of financing related to water treatment facility arrangement |
( |
) | ( |
) | ( |
) | ||||||
Others |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Net cash used in financing activities |
( |
) | ( |
) | ( |
) | ||||||
Effect of exchange rates on cash and cash equivalents |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Net increase (decrease) in cash and cash equivalents |
( |
) | ||||||||||
Cash and cash equivalents at beginning of period |
||||||||||||
|
|
|
|
|
|
|||||||
Cash and cash equivalents at end of period |
$ | $ | $ | |||||||||
|
|
|
|
|
|
|||||||
Supplemental cash flow information |
||||||||||||
Cash paid for interest |
$ | $ | $ | |||||||||
Cash paid for income taxes |
$ | $ | $ | |||||||||
Non-cash investing and financing activities |
||||||||||||
Property, plant and equipment additions in other accounts payable |
$ | $ | — | $ | ||||||||
Acquisition of treasury stock to satisfy the tax withholding obligations in connection with equity-based compensation |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Exchange of exchangeable senior notes into common stock |
$ |
$ |
— |
$ |
— |
Buildings |
||||
Building related structures |
||||
Machinery and equipment |
||||
Others |
Year Ended December 31, |
||||||||
2020 |
2019 |
|||||||
(In thousands of U.S. dollars) |
||||||||
Revenues: |
||||||||
Net sales—Foundry Services Group |
$ | $ | ||||||
Net sales—transitional Fab 3 foundry services |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total revenues |
||||||||
Cost of sales: |
||||||||
Cost of sales—Foundry Services Group |
||||||||
Cost of sales—transitional Fab 3 foundry services |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total cost of sales |
||||||||
|
|
|
|
|||||
Gross profit |
||||||||
Operating expenses: |
||||||||
Selling, general and administrative expenses |
||||||||
Research and development expenses |
||||||||
Restructuring and other charges |
||||||||
|
|
|
|
|||||
Total operating expenses |
||||||||
Operating income from discontinued operations |
||||||||
|
|
|
|
|||||
Foreign currency gain, net |
||||||||
Others, net |
( |
) | ||||||
|
|
|
|
|||||
Income from discontinued operations before income tax expense |
||||||||
Income tax expense |
||||||||
Gain on sale of discontinued operations |
— | |||||||
Transaction costs |
( |
) | — | |||||
|
|
|
|
|||||
Income (loss) from discontinued operations, net of tax |
( |
) | ||||||
|
|
|
|
Year Ended December 31, |
||||||||
2020 |
2019 |
|||||||
(In thousands of U.S. dollars) |
||||||||
Significant non-cash operating activities: |
||||||||
Depreciation and amortization |
$ | $ | ||||||
Provision for severance benefits |
||||||||
Stock-based compensation |
||||||||
Investing activities: |
||||||||
Capital expenditures |
$ | ( |
) | $ | ( |
) |
Carrying Value December 31, 2021 |
Fair Value Measurement December 31, 2021 |
Quoted Prices in Active Markets for Identical Liability (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Unobservable Inputs (Level 3) |
||||||||||||||||
Liabilities: |
||||||||||||||||||||
Derivative liabilities (other current liabilities) |
$ | $ | — | $ | — |
Carrying Value December 31, 2020 |
Fair Value Measurement December 31, 2020 |
Quoted Prices in Active Markets for Identical Asset / Liability (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Unobservable Inputs (Level 3) |
||||||||||||||||
Assets: |
||||||||||||||||||||
Derivative assets (other current assets) |
$ | $ | — | $ | — | |||||||||||||||
Liabilities: |
||||||||||||||||||||
Derivative liabilities (other current liabilities) |
$ | $ | — | $ | — |
December 31, 2020 |
||||||||
Carrying Value |
Fair Value |
|||||||
(In thousands of U.S. dollars) |
||||||||
Borrowings: |
||||||||
$ | $ |
December 31, |
||||||||
2021 |
2020 |
|||||||
Accounts receivable |
$ | $ | ||||||
Notes receivable |
||||||||
Less: |
||||||||
Allowance for credit losses |
( |
) | ( |
) | ||||
Sales return reserves |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Accounts receivable, net |
$ | $ | ||||||
|
|
|
|
Year Ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
Beginning balance |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Provision |
( |
) | ( |
) | — | |||||||
Translation adjustments |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Ending balance |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
|
|
|
|
|
|
Year Ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
Beginning balance |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Reversal (provision) |
( |
) | ( |
) | ||||||||
Usage |
— | |||||||||||
Translation adjustments |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Ending balance |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
|
|
|
|
|
|
December 31, |
||||||||
2021 |
2020 |
|||||||
Finished goods |
$ | $ | ||||||
Semi-finished goods and work-in-process |
||||||||
Raw materials |
||||||||
Materials in-transit |
||||||||
Less: inventory reserve |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Inventories, net |
$ | $ | ||||||
|
|
|
|
Year Ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
Beginning balance |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Change in reserve |
||||||||||||
Inventory reserve charged to costs of sales |
( |
) | ( |
) | ( |
) | ||||||
Sale of previously reserved inventory |
||||||||||||
|
|
|
|
|
|
|||||||
( |
) | ( |
) | ( |
) | |||||||
Write off |
||||||||||||
Translation adjustments |
( |
) | ||||||||||
Reclassified to assets held for sale |
— | — | ||||||||||
|
|
|
|
|
|
|||||||
Ending balance |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
|
|
|
|
|
|
December 31, |
||||||||
2021 |
2020 |
|||||||
Buildings and related structures |
$ | $ | ||||||
Machinery and equipment |
||||||||
Finance lease right-of-use |
||||||||
Others |
||||||||
|
|
|
|
|||||
Less: accumulated depreciation |
( |
) | ( |
) | ||||
Land |
||||||||
Construction in progress |
||||||||
|
|
|
|
|||||
Property, plant and equipment, net |
$ | $ | ||||||
|
|
|
|
December 31, 2021 |
||||||||||||
Gross amount |
Accumulated amortization |
Net amount |
||||||||||
Intellectual property assets |
$ | $ | ( |
) | $ | |||||||
|
|
|
|
|
|
|||||||
Intangible assets |
$ | $ | ( |
) | $ | |||||||
|
|
|
|
|
|
December 31, 2020 |
||||||||||||
Gross amount |
Accumulated amortization |
Net amount |
||||||||||
Intellectual property assets |
$ | $ | ( |
) | $ | |||||||
|
|
|
|
|
|
|||||||
Intangible assets |
$ | $ | ( |
) | $ | |||||||
|
|
|
|
|
|
December 31, |
||||||||||
Leases |
Classification |
2021 |
2020 |
|||||||
Assets |
||||||||||
Operating lease |
Operating lease right-of-use |
$ | |
|
$ | |||||
Finance lease |
P | , net |
|
|||||||
|
|
|
|
|
|
|||||
Total lease assets |
$ | |
|
$ | ||||||
|
|
|
|
|
|
|||||
Liabilities |
|
|
||||||||
Current |
|
|
||||||||
Operating |
Operating lease liabilities | $ | |
|
$ | |||||
Finance |
s | |
|
|||||||
Non-current |
|
|
||||||||
Operating |
Non-current operating lease liabilities |
|
|
|||||||
Finance |
Other non-current |
|
|
|||||||
|
|
|
|
|
|
|||||
Total lease liabilities |
$ | |
|
$ | ||||||
|
|
|
|
|
|
December 31, |
||||||||
2021 |
2020 |
|||||||
Weighted average remaining lease term |
||||||||
Operating leases |
||||||||
Finance leases |
||||||||
Weighted average discount rate |
||||||||
Operating leases |
% | % | ||||||
Finance leases |
% | % |
Year Ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
Operating lease cost |
$ | $ | $ | |||||||||
Finance lease cost |
||||||||||||
Amortization of right-of-use |
||||||||||||
Interest on lease liabilities |
||||||||||||
|
|
|
|
|
|
|||||||
Total lease cost |
$ | $ | $ | |||||||||
|
|
|
|
|
|
Year Ended |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
Cash paid for amounts included in the measurement of lease liabilities |
||||||||||||
Operating cash flows from operating leases |
$ | $ | $ | |||||||||
Operating cash flows from finance leases |
||||||||||||
Financing cash flows from finance leases |
Operating Leases |
Finance Leases |
|||||||
2022 |
$ | $ | ||||||
2023 |
||||||||
2024 |
||||||||
2025 |
||||||||
2026 |
||||||||
|
|
|
|
|||||
Total future lease payments |
||||||||
Less: Imputed interest |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Present value of future payments |
$ | $ | ||||||
|
|
|
|
December 31, |
||||||||
2021 |
2020 |
|||||||
Payroll, benefits and related taxes, excluding severance benefits |
$ | $ | ||||||
Withholding tax attributable to intercompany interest income |
||||||||
Interest on Exchangeable Notes |
— | |||||||
Outside service fees |
||||||||
Restructuring and others |
— | |||||||
Merger-related costs |
||||||||
Others |
||||||||
|
|
|
|
|||||
Accrued expenses |
$ | $ | ||||||
|
|
|
|
Date of transaction |
Type of derivative |
Total notional amount |
Month of settlement | |||||||
|
|
|
$ | |||||||
|
|
|
$ |
Date of transaction |
Type of derivative |
Total notional amount |
Month of settlement | |||||||
|
|
|
$ | |||||||
|
|
|
$ | |||||||
|
|
|
$ |
Derivatives designated as hedging instruments: |
December 31, |
|||||||||||
2021 |
2020 |
|||||||||||
Asset Derivatives: |
||||||||||||
Zero cost collars |
Other current assets | $ | $ | |||||||||
Liability Derivatives: |
||||||||||||
Zero cost collars |
Other current liabilities | $ | $ |
As of December 31, 2021 |
Gross amounts of recognized liabilities |
Gross amounts offset in the balance sheets |
Net amounts of liabilities presented in the balance sheets |
Gross amounts not offset in the balance sheets |
Net amount |
|||||||||||||||||||
Financial instruments |
Cash collateral pledged |
|||||||||||||||||||||||
Liability Derivatives: |
||||||||||||||||||||||||
Zero cost collars |
$ | $ | — | $ | $ | — | $ | ( |
) | $ | ( |
) |
As of December 31, 2020 |
|
Gross amounts of recognized assets/liabilities |
|
|
Gross amounts offset in the balance sheets |
|
|
Net amounts of assets/liabilities presented in the balance sheets |
|
|
Gross amounts not offset in the balance sheets |
|
|
Net amount |
| |||||||||
|
Financial instruments |
|
|
Cash collateral pledged |
| |||||||||||||||||||
Asset Derivatives: |
|
|
|
|
|
|
||||||||||||||||||
Zero cost collars |
$ | $ | — | $ | $ | — | $ | — | $ | |||||||||||||||
Liability Derivatives: |
||||||||||||||||||||||||
Zero cost collars |
$ | $ | — | $ | $ | — | $ | — | $ |
Derivatives in ASC 815 Cash Flow Hedging Relationships |
Amount of Gain (Loss) Recognized in AOCI on Derivatives |
Location/Amount of Gain (Loss) Reclassified from AOCI Into Statement of Operations |
Location/Amount of Gain Recognized in Statement of Operations on Derivatives |
|||||||||||||||||||||||||||||
2021 |
2020 |
2021 |
2020 |
2021 |
2020 |
|||||||||||||||||||||||||||
Zero cost collars |
$ | ( |
) | $ | Net sales | $ | ( |
) | $ | Other income, net | $ | $ |
December 31, |
||||||||
Counterparties |
2021 |
2020 |
||||||
NFIK |
$ | $ | ||||||
DB |
||||||||
SC |
||||||||
|
|
|
|
|||||
Total |
$ | $ | ||||||
|
|
|
|
Year Ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
Beginning balance |
$ | $ | $ | |||||||||
Provision (reversal) |
( |
) | ( |
) | ||||||||
Usage |
( |
) | ( |
) | ( |
) | ||||||
Translation adjustments |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Ending balance |
$ | $ | $ | |||||||||
|
|
|
|
|
|
December 31, |
||||
2020 |
||||
|
$ | |||
Less: unamortized discount and debt issuance costs |
( |
) | ||
|
|
|||
Current portion of long-term borrowings, net |
$ | |||
|
|
Year Ended December 31, |
||||||||
2021 |
2020 |
|||||||
Beginning balance |
$ | $ | ||||||
Provisions |
||||||||
Severance payments |
( |
) | ( |
) | ||||
Translation adjustments |
( |
) | ||||||
|
|
|
|
|||||
Less: Cumulative contributions to severance insurance deposit accounts |
( |
) | ( |
) | ||||
The National Pension Fund |
( |
) | ( |
) | ||||
Group severance insurance plan |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Accrued severance benefits, net |
$ | $ | ||||||
|
|
|
|
Severance Benefit |
||||
2022 |
$ | |||
2023 |
||||
2024 |
||||
2025 |
||||
2026 |
||||
2027 – 2031 |
Number of Restricted Stock Units |
Weighted Average Grant-Date Fair Value of Restricted Stock Units |
|||||||
Outstanding at December 31, 2020 |
$ | |||||||
Granted |
||||||||
Vested |
( |
) | ||||||
Forfeited |
( |
) | ||||||
|
|
|
|
|||||
Outstanding at December 31, 2021 |
$ | |||||||
|
|
|
|
Number of Options |
Weighted Average Exercise Price of Stock Options |
Aggregate Intrinsic Value of Stock Options |
Weighted Average Remaining Contractual Life of Stock Options |
|||||||||||||
Outstanding at January 1, 2021 |
$ | $ | ||||||||||||||
Exercised |
( |
) | — | |||||||||||||
|
|
|||||||||||||||
Outstanding at December 31, 2021 |
$ | $ | ||||||||||||||
|
|
|||||||||||||||
Vested and Exercisable at December 31, 2021 |
$ | $ | ||||||||||||||
|
|
Year Ended December 31, |
||||||||||||||||||||||||
2021 |
2020 |
2019 |
||||||||||||||||||||||
Number |
Weighted Average Grant- Date Fair Value |
Number |
Weighted Average Grant- Date Value |
Number |
Weighted Average Grant- Date Fair Value |
|||||||||||||||||||
Unvested options at the beginning of the period |
$ | |||||||||||||||||||||||
Vested options during the period |
( |
) | ||||||||||||||||||||||
Forfeited options during the period |
( |
) | ||||||||||||||||||||||
Exercised options during the period |
( |
) | ||||||||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||
Unvested options at the end of the period |
— | $ | ||||||||||||||||||||||
|
|
|
|
|
|
Year Ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
Income (loss) from continuing operations before income tax expense |
||||||||||||
Domestic |
$ | $ | ( |
) | $ | ( |
) | |||||
Foreign |
||||||||||||
|
|
|
|
|
|
|||||||
( |
) | |||||||||||
|
|
|
|
|
|
|||||||
Current income tax expense (benefit) |
||||||||||||
Domestic |
||||||||||||
Foreign |
( |
) | ||||||||||
Uncertain tax position liability (domestic) |
— | — | ( |
) | ||||||||
Uncertain tax position liability (foreign) |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
( |
) | |||||||||||
|
|
|
|
|
|
|||||||
Deferred income tax benefit |
||||||||||||
Domestic |
( |
) | — | |||||||||
Foreign |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
( |
) | |||||||||||
|
|
|
|
|
|
|||||||
Benefits from intra-period allocation |
— | — | ( |
) | ||||||||
Total income tax expense (benefit) |
$ | $ | ( |
) | $ | |||||||
|
|
|
|
|
|
|||||||
Effective tax rate |
% | — | — | |||||||||
|
|
|
|
|
|
Year Ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
Provision computed at statutory rates |
$ | $ | $ | ( |
) | |||||||
State income taxes, net of federal effect |
— | ( |
) | |||||||||
Change in statutory tax rates |
( |
) | ||||||||||
Difference in foreign tax rates |
||||||||||||
Permanent differences |
||||||||||||
Derivative assets adjustment |
( |
) | ||||||||||
TPECs, hybrid and other interest |
( |
) | ( |
) | ||||||||
Thin capitalization |
— | |||||||||||
Equity-based compensation |
( |
) | ( |
) | ( |
) | ||||||
Permanent foreign currency gain (loss) |
( |
) | ( |
) | ||||||||
Penalty |
||||||||||||
GILTI |
||||||||||||
Intercompany debt restructuring |
( |
) | ||||||||||
Other permanent differences |
( |
) | ||||||||||
Withholding tax |
||||||||||||
State net operating loss write-off |
— | — | ||||||||||
Change in valuation allowance |
( |
) | ( |
) | ||||||||
Benefits from intra-period allocation |
— | — | ( |
) | ||||||||
Tax credits claimed |
( |
) | ( |
) | ( |
) | ||||||
Tax credits expired |
— | — | ||||||||||
Uncertain tax positions liability |
( |
) | ( |
) | ||||||||
Change in net operating loss carry-forwards |
( |
) | — | |||||||||
Foreign local taxes |
||||||||||||
Others |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Income tax expense (benefit) |
$ | $ | ( |
) | $ | |||||||
|
|
|
|
|
|
Year Ended December 31, |
||||||||
2021 |
2020 |
|||||||
Deferred tax assets |
||||||||
Inventory reserves |
$ | $ | ||||||
Accrued expenses |
||||||||
Property, plant and equipment |
||||||||
Accumulated severance benefits |
||||||||
Operating lease right-of-use |
||||||||
Foreign currency translation loss |
||||||||
NOL carry-forwards |
||||||||
Tax credit carry-forwards |
||||||||
Other long-term payable |
||||||||
Interest expense deduction limitation |
— | |||||||
Derivative liabilities |
— | |||||||
Others |
||||||||
|
|
|
|
|||||
Total deferred tax assets |
||||||||
Less: Valuation allowance |
( |
) | ( |
) | ||||
|
|
|
|
|||||
|
|
|
|
|||||
Deferred tax liabilities |
||||||||
Derivative assets |
— | |||||||
Prepaid expense |
||||||||
Severance benefit deposits |
||||||||
Operating lease right-of-use |
||||||||
Foreign currency translation gain |
||||||||
Others |
||||||||
|
|
|
|
|||||
Total deferred tax liabilities |
||||||||
|
|
|
|
|||||
Net deferred tax assets |
$ | $ | ||||||
|
|
|
|
Year Ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
Beginning balance |
$ | $ | $ | |||||||||
Additions |
— | — | ||||||||||
Reductions |
( |
) | ( |
) | — | |||||||
Changes relating to the discontinued operations |
— | ( |
) | — | ||||||||
NOL/tax credit claimed/expired |
— | ( |
) | |||||||||
Translation adjustments |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Ending balance |
$ | $ | $ | |||||||||
|
|
|
|
|
|
Year Ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
NOL carry-forwards |
$ | $ | $ |
Year Ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
Unrecognized tax benefits, balance at the beginning |
$ | $ | $ | |||||||||
Additions based on tax positions related to the current year |
||||||||||||
Reductions for tax positions of prior years |
— | ( |
) | ( |
) | |||||||
Lapse of statute of limitations |
( |
) |
( |
) | — | |||||||
Translation adjustments |
||||||||||||
|
|
|
|
|
|
|||||||
Unrecognized tax benefits, balance at the ending |
$ | $ | $ | |||||||||
|
|
|
|
|
|
Year Ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
Revenues |
||||||||||||
Standard products business |
||||||||||||
Display Solutions |
$ | $ | $ | |||||||||
Power Solutions |
||||||||||||
|
|
|
|
|
|
|||||||
Total standard products business |
||||||||||||
Transitional Fab 3 foundry services |
||||||||||||
|
|
|
|
|
|
|||||||
Total revenues |
$ | $ | $ | |||||||||
|
|
|
|
|
|
Year Ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
Gross Profit |
||||||||||||
Standard products business |
$ | $ | $ | |||||||||
Transitional Fab 3 foundry services |
— | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Total gross profit |
$ | $ | $ |
Year Ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
Korea |
$ | $ | $ | |||||||||
Asia Pacific (other than Korea) |
||||||||||||
United States |
||||||||||||
Europe |
||||||||||||
Others |
||||||||||||
|
|
|
|
|
|
|||||||
Total |
$ | $ | $ | |||||||||
|
|
|
|
|
|
Year Ended December 31, |
||||||||
2021 |
2020 |
|||||||
Foreign currency translation adjustments |
$ | ( |
) | $ | ||||
Derivative adjustments |
( |
) | ||||||
|
|
|
|
|||||
Total |
$ | ( |
) | $ | ||||
|
|
|
|
Year Ended December 31, 2021 |
Foreign currency translation adjustments |
Derivative adjustments |
Total |
|||||||||
Beginning balance |
$ | $ | $ | |||||||||
|
|
|
|
|
|
|||||||
Other comprehensive loss before reclassifications |
( |
) | ( |
) | ( |
) | ||||||
Amounts reclassified from accumulated other comprehensive loss |
— | |||||||||||
|
|
|
|
|
|
|||||||
Net current-period other comprehensive loss |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Ending balance |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
|
|
|
|
|
|
Year Ended December 31, 2020 |
Foreign currency translation adjustments |
Derivative adjustments |
Total |
|||||||||
Beginning balance |
$ | ( |
) | $ | $ | ( |
) | |||||
|
|
|
|
|
|
|||||||
Other comprehensive income before reclassifications |
||||||||||||
Amounts reclassified from accumulated other comprehensive income |
— | ( |
) | ( |
) | |||||||
|
|
|
|
|
|
|||||||
Net current-period other comprehensive income |
||||||||||||
|
|
|
|
|
|
|||||||
Ending balance |
$ | $ | $ | |||||||||
|
|
|
|
|
|
Year Ended December 31, 2019 |
Foreign currency translation adjustments |
Derivative adjustments |
Total |
|||||||||
Beginning balance |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
|
|
|
|
|
|
|||||||
Other comprehensive income (loss) before reclassifications |
( |
) | ||||||||||
Amounts reclassified from accumulated other comprehensive loss |
— | |||||||||||
|
|
|
|
|
|
|||||||
Net current-period other comprehensive income |
||||||||||||
|
|
|
|
|
|
|||||||
Ending balance |
$ | ( |
) | $ | $ | ( |
) | |||||
|
|
|
|
|
|
Year Ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
(In thousands of U.S. dollars, except share data) |
||||||||||||
Basic earnings (loss) per share |
||||||||||||
Income (loss) from continuing operations |
$ | $ | $ | ( |
) | |||||||
Income (loss) from discontinued operations, net of tax |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Net income (loss) |
$ | $ | $ | ( |
) | |||||||
|
|
|
|
|
|
|||||||
Basic weighted average common stock outstanding |
||||||||||||
Basic earnings (loss) per common share |
||||||||||||
Continuing operations |
$ | $ | $ | ( |
) | |||||||
Discontinued operations |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Total |
$ | $ | $ | ( |
) | |||||||
|
|
|
|
|
|
|||||||
Diluted earnings (loss) per share |
||||||||||||
Income (loss) from continuing operations |
$ | $ | $ | ( |
) | |||||||
Add back: Interest expense on Exchangeable Notes |
— | |||||||||||
|
|
|
|
|
|
|||||||
Income (loss) from continuing operations allocated to common stockholders |
$ | $ | $ | ( |
) | |||||||
Income (loss) from discontinued operations, net of tax |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Net income (loss) allocated to common stockholders |
$ | $ | $ | ( |
) | |||||||
|
|
|
|
|
|
|||||||
Basic weighted average common stock outstanding |
||||||||||||
Net effect of dilutive equity awards |
— | |||||||||||
Net effect of assumed conversion of |
— | |||||||||||
|
|
|
|
|
|
|||||||
Diluted weighted average common stock outstanding |
||||||||||||
Diluted earnings (loss) per common share |
||||||||||||
Continuing operations |
$ | $ | $ | ( |
) | |||||||
Discontinued operations |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Total |
$ | $ | $ | ( |
) | |||||||
|
|
|
|
|
|
Year Ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
Options |
||||||||||||
Restricted Stock Units |
— |
1. | Financial Statements |
2. | Financial Statement Schedules |
3. | Exhibits |
(1) | Certain portions of this document have been omitted pursuant to a grant of confidential treatment by the SEC. |
* | Management contract, compensatory plan or arrangement |
# | Filed herewith |
† | Furnished herewith |
By: | /s/ Young-Joon Kim | |||
Name: | Young-Joon Kim | |||
Title: | Chief Executive Officer and Director | |||
Date: | February 23, 2022 |
Date | ||
/s/ Young-Joon Kim |
February 23, 2022 | |
Young-Joon Kim, Chief Executive Officer and Director (Principal Executive Officer) |
||
/s/ Shin Young Park |
February 23, 2022 | |
Shin Young Park, Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) |
||
/s/ Melvin Keating |
February 23, 2022 | |
Melvin Keating, Director |
||
/s/ Ilbok Lee |
February 23, 2022 | |
Ilbok Lee, Director |
||
/s/ Camillo Martino |
February 23, 2022 | |
Camillo Martino, Non-Executive Chairman of the Board of Directors |
||
/s/ Gary Tanner |
February 23, 2022 | |
Gary Tanner, Director |
||
/s/ Liz Chung |
February 23, 2022 | |
Liz Chung, Director |
Exhibit 4.1
DESCRIPTION OF REGISTRANTS SECURITIES
The following brief description of the capital stock of Magnachip Semiconductor Corporation (us, our, we, or the Company) is a summary. This summary is not complete and is subject to and qualified in its entirety by reference to the complete text of our Certificate of Incorporation (Certificate of Incorporation), and our Amended and Restated Bylaws (Bylaws) previously filed with the U.S. Securities and Exchange Commission and incorporated by reference as an exhibit to this Annual Report on Form 10-K of which this Exhibit 4.1 forms a part. We encourage you to read the Certificate of Incorporation and Bylaws carefully.
General
The Certificate of Incorporation provides that the Company may issue 155,000,000 shares of capital stock, of which 150,000,000 shares are designated as common stock, par value $0.01 per share, and 5,000,000 shares are designated as of preferred stock, par value $0.01 per share.
Common Stock
Voting Rights
Holders of our common stock are entitled to one vote for each share held of record on all matters submitted to a vote of the stockholders. Our stockholders do not have cumulative voting rights in the election of directors. Except as required by law or our Certificate of Incorporation and Bylaws, the vote of a majority of the shares represented in person or by proxy at any meeting at which a quorum is present will be sufficient for the transaction of any business at a meeting.
Dividends
Subject to preferences held by, or that may be granted to, any outstanding shares of preferred stock, holders of our common stock will be entitled to receive ratably those dividends as may be declared by our board of directors out of funds legally available for such distributions, as well as any other distributions made to our stockholders.
Other Rights
In the event of our liquidation, dissolution or winding up, holders of our common stock are entitled to share ratably in all of our assets remaining after we pay our liabilities and any liquidation preferences granted to the holders of outstanding shares of preferred stock.
Holders of our common stock have no preemptive or other subscription or conversion rights.
There are no redemption or sinking fund provisions applicable to our common stock.
Preferred Stock
The Certificate of Incorporation authorizes the issuance of 5,000,000 shares of blank check preferred stock with such designation, rights and preferences as may be determined from time to time by our board of directors. Accordingly, our board of directors is empowered, without stockholder approval, to issue preferred stock with dividend, liquidation, conversion, voting or other rights which could adversely affect the voting power or other rights of the holders of common stock. The preferred stock could be utilized as a method of discouraging, delaying or preventing a change in control of us.
Rights Agreement
On December 12, 2021, our Board of Directors authorized and declared a dividend of one preferred stock purchase right (a Right and collectively, the Rights) for each share of the Companys common stock, par value $0.01 per share (the Common Stock), outstanding at the close of business on December 23, 2021 (the Record Date). Each Right, once exercisable, will entitle the
registered holder to purchase from the Company one one-thousandth of a share of Series A-1 Junior Participating Preferred Stock, par value $0.01 per share (the Preferred Stock), at a purchase price of $80, subject to adjustment (the Purchase Price). The specific terms of the Rights are contained in the Rights Agreement, dated as of December 13, 2021 by and between the Company and American Stock Transfer & Trust Company, LLC, as Rights Agent (the Rights Agreement).
The following summary of the principal terms of the Rights Agreement is a general description only and is qualified in its entirety by the full text of the Rights Agreement which is attached as Exhibit 4.2 to this Annual Report on Form 10-K and incorporated by reference herein. Capitalized terms used but not otherwise defined herein will have meanings given to such terms in the Rights Agreement.
The Rights
Initially, the Rights will trade with, and will be inseparable from, the Common Stock. The Rights will be evidenced (unless earlier expired, redeemed or terminated) by the certificates for the Common Stock (or, in the case of uncertificated shares of Common Stock, by the book-entry account that evidences record ownership of such shares) and not by separate Right Certificates. The registered holders of the Common Stock will be deemed to be the registered holders of the associated Rights. Rights are issued to all shares of Common Stock outstanding as of the Record Date or issued (on original issuance or out of treasury) after the Record Date but before the earlier of the Distribution Date described below and the Expiration Date. Before the exercise of the Rights, the Rights do not give their holders any rights as stockholders of the Company, including the right to vote or to receive dividends.
Exercisability
The Rights become exercisable and separate from the Common Stock on the Distribution Date. The Distribution Date means the earlier of:
| The tenth day after the public announcement or disclosure by the Company or any person or group of affiliated or associated persons that any person or group of affiliated or associated persons has become an Acquiring Person by obtaining beneficial ownership of 12.5% (or 20% in the case of a Passive Institutional Investor) or more of the Companys outstanding Common Stock (the Stock Acquisition Date) (or, if the Board determines on or before such tenth day to effect an exchange in accordance with the terms of the Rights Agreement and determines that a later date is advisable, such later date that is not more than twenty days after the Stock Acquisition Date); or |
| The tenth business day (or such later date as the Board of Directors may designate before a person or group of affiliated or associated persons becomes an Acquiring Person) after the commencement of, or first public announcement of the intent of any person to commence, a tender or exchange offer by any person or group of affiliated or associated persons, which would, if consummated, result in such person or group becoming an Acquiring Person; |
The Distribution Date shall in no event be prior to the Record Date.
Passive Institutional Investor is defined generally as any person who has reported beneficial ownership of shares of Common Stock on Schedule 13G under the Securities Exchange Act of 1934 (the Exchange Act).
A person beneficially owns securities that such person or any of its affiliates or associates, directly or indirectly, beneficially owns (as determined pursuant to Rule 13d-3 and Rule 13d-5 under the Exchange Act as in effect on the date hereof), or, subject to certain exceptions, has the right or obligation to acquire or to vote pursuant to any agreement, arrangement or understanding or upon the exercise of conversion rights, exchange rights, rights, warrants or options or otherwise. A person shall also be deemed to beneficially own any securities that are beneficially owned, directly or indirectly, by any other person (or any of its affiliates or associates) and with respect to such person (or its affiliates or associates) has any agreement, arrangement or understanding for the purpose of acquiring, holding voting or disposing any such securities or are in respect of any Synthetic Long Positions held by such person or its affiliates or associates that (1) are disclosed pursuant to a Schedule 13D or Schedule 13G under the Exchange Act or (2) if not disclosed on a Schedule 13D or Schedule 13G, if and only if the Board determines that such person shall be deemed to be the beneficial owner of, and to beneficially own, the Common Stock in respect of such Synthetic Long Positions. A Synthetic Long Position is any option, warrant, swap, participation, convertible security, stock appreciation right or other right or derivative transaction (in each case other than the Rights), whether or not presently exercisable, that has an exercise or conversion privilege or a settlement payment or mechanism at a price related to Common Stock or a value determined in whole or in part with reference to, or derived in whole or in part from, the market price or value of Common Stock (without regard to whether (a) such right or derivative transaction conveys any voting rights in such Common Stock to such Person, (b) such right or derivative transaction is subject to settlement in whole or in part in cash, Common Stock or other property or (c) such Person may have entered into other transactions that hedge or offset the economic effect of such right or derivative transaction) and that increases in value as the value of Common Stock increases or that provides to the holder of such right an opportunity, directly or indirectly, to profit or share in any profit derived from any increase in the value of Common Stock.
The Rights will not become exercisable due solely to the ownership of Common Stock by existing stockholders who own 12.5% (or 20% in the case of a Passive Institutional Investor) or more of the Companys outstanding Common Stock as of the date of the Rights Agreement unless any such stockholder increases its Beneficial Ownership of the Common Stock to an amount equal to or greater than the greater of (i) 12.5% (or 20% in the case of a Passive Institutional Investor) and (ii) the sum of (x) the lowest Beneficial Ownership of such stockholder as a percentage of the outstanding Common Stock as of any time from and after the date of the Rights Agreement plus (y) 1.0%. Furthermore, the Rights will not be exercisable if the Companys Board of Directors determines in good faith that a person or group of affiliated or associated persons has become an Acquiring Person inadvertently and such person or group reduces its holdings below 12.5% (or 20% in the case of a Passive Institutional Investor) of the Companys outstanding Common Stock as promptly as practicable. Finally, the Rights will not be exercisable if the Company repurchases some of its own Common Stock and, as a result, a persons or groups holdings constitute 12.5% (or 20% in the case of a Passive Institutional Investor) or more of the remaining outstanding Common Stock so long as such person or group does not make any further acquisitions of the Common Stock after the repurchase.
Issuance of Right Certificates
Before the Distribution Date, the Rights will be evidenced by the Common Stock certificates (or, if the Common Stock is uncertificated, by the book-entry account that evidences record ownership of such Common Stock) and will be transferred with and only with such Common Stock certificates. After the Distribution Date, the Rights Agent will mail separate certificates evidencing the Rights to each record holder of the Common Stock (or, if so agreed by the Company and Rights Agent in the case of uncertificated Common Stock, by appropriate changes to the book-entry account that evidences record ownership of such Common Stock) at the close of business on the Distribution Date. Thereafter, the Rights will be transferable separately from the Common Stock. Any Rights held by an Acquiring Person are null and void and may not be exercised.
Consequences of a Person or Group Becoming an Acquiring Person
| Flip-In. If any person or group of affiliated or associated persons becomes an Acquiring Person, then, after the Distribution Date, each Right (other than Rights beneficially owned by the Acquiring Person and certain affiliated persons or transferees thereof) will entitle the holder to purchase, for the Purchase Price, a number of shares of Common Stock having a market value of twice the Purchase Price. |
| Flip-Over. Alternatively, if, after any person or group of affiliated or associated persons becomes an Acquiring Person, (1) the Company is involved in a merger or other business combination in which the Company is not the surviving corporation or its Common Stock is changed into or exchanged for other securities or assets; or (2) the Company or one or more of its subsidiaries sell or otherwise transfer assets or earning power aggregating more than 50% of the assets or earning power of the Company and its subsidiaries, taken as a whole, then each Right will entitle the holder to purchase, for the Purchase Price, a number of shares of common stock of the other party to such business combination or sale (or in certain circumstances, an affiliate) having a market value of twice the Purchase Price. |
Expiration
The Rights will expire at the close of business on December 12, 2022 unless earlier redeemed or exchanged by the Company, as discussed below.
Redemption
The Board of Directors may redeem all of the Rights for $0.001 per Right at any time before any person or group of affiliated or associated persons becomes an Acquiring Person. If the Board redeems any Right, it must redeem all of the Rights. Once the Rights are redeemed, the right to exercise the Right will terminate and, thereafter, the only right of the Rights holders will be to receive the redemption price of $0.001 per Right. The redemption price may be adjusted to reflect any stock split, stock dividend or similar transaction occurring after the date of the Rights Agreement.
Exchange
At any time on or after any person or group of affiliated or associated persons becomes an Acquiring Person (but before any person or group of affiliated or associated persons becomes the owner of 50% or more of the Companys outstanding Common Stock), the Board of Directors may exchange all or part of the Rights (other than the Rights beneficially owned by the Acquiring Person and certain affiliated persons) for shares of Common Stock at an exchange ratio of one share of Common Stock per Right.
Anti-Dilution Provisions
The Board of Directors may adjust the Purchase Price of the Preferred Stock, the number and kind of shares of Preferred Stock issuable and the number of outstanding Rights to prevent dilution that may occur from a stock dividend, stock split or reclassification of the Preferred Stock. No adjustments to the Purchase Price of less than 1% will be made.
Amendments
For so long as the Rights are redeemable, the Rights Agreement may be amended in any respect without the approval of any holders of shares of Common Stock. At any time when the Rights are no longer redeemable, the Company may amend the Rights Agreement without the approval of any Rights holders if the amendment does not (i) adversely affect the interests of the Rights holders as such (other than any Acquiring Person and certain affiliated persons); (ii) cause the Rights Agreement again to become amendable other than in accordance with the Rights Agreement; or (iii) cause the Rights again to become redeemable.
Preferred Stock Provisions
Each share of Preferred Stock, if issued:
| will not be redeemable; |
| will entitle holders to receive, when, as and if declared by the Board of Directors, quarterly dividend payments in an amount per share equal to 1,000 times the aggregate per share amount of all cash dividends, and 1,000 times the aggregate per share amount (payable in kind) of all non-cash dividends or other distributions other than a dividend payable in shares of Common Stock or a subdivision of the outstanding shares of Common Stock (by reclassification or otherwise), declared on the Common Stock since the immediately preceding Quarterly Dividend Payment Date, or, with respect to the first Quarterly Dividend Payment Date, since the first issuance of any share or fraction of a share of Series A-1 Junior Participating Preferred Stock; |
| will entitle holders upon liquidation to $1,000 per share of the Preferred Stock, plus an amount equal to accrued and unpaid dividends and distributions thereon, whether or not declared, to the date of such payment; |
| will entitle holders to the same voting power as one thousand shares of Common Stock on all matters submitted to a vote of the stockholders of the Company, and each fractional share of the Preferred Stock will entitle the holder thereof to a pro rata fractional vote; and |
| will entitle holders to a per share payment equal to one thousand times the aggregate amount of stock, securities, cash and any other property (payable in kind), as the case may be, into which or for which each share of Common Stock is changed or exchanged via merger, consolidation, or a similar transaction. |
Each authorized fractional share of Preferred Stock will entitle the holder thereof to a pro rata fraction of the foregoing. The value of one one-thousandth of a share of Preferred Stock should approximate the value of one share of Common Stock.
Certain Anti-Takeover Effects of Delaware Law
We are subject to the provisions of Section 203 of the Delaware General Corporation Law (the DGCL), regulating corporate takeovers and which has an anti-takeover effect with respect to transactions not approved in advance by our board of directors, including discouraging takeover attempts that might result in a premium over the market price for shares of our common stock. In general, those provisions prohibit a Delaware corporation from engaging in any business combination with any interested stockholder for a period of three years following the date that the stockholder became an interested stockholder, unless:
| the transaction is approved by the board of directors before the date the interested stockholder attained that status; |
| upon consummation of the transaction which resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced; or |
| on or after such date, the business combination is approved by the board of directors and authorized at a meeting of stockholders, and not by written consent, by at least two-thirds of the outstanding voting stock that is not owned by the interested stockholder. |
In general, DGCL Section 203 defines a business combination to include the following:
| any merger or consolidation involving the corporation and the interested stockholder; |
| any sale, transfer, pledge or other disposition of 10% or more of the assets of the corporation involving the interested stockholder; |
| subject to certain exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder; |
| any transaction involving the corporation that has the effect of increasing the proportionate share of the stock of any class or series of the corporation beneficially owned by the interested stockholder; or |
| the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits provided by or through the corporation. |
In general, DGCL Section 203 defines an interested stockholder as any entity or person beneficially owning 15% or more of the outstanding voting stock of the corporation and any entity or person affiliated with or controlling or controlled by any such entity or person.
A Delaware corporation may opt out of this provision by express provision in its original certificate of incorporation or by amendment to its certificate of incorporation or bylaws approved by its stockholders. However, we have not opted out of this provision.
Certain Provisions of the Certificate of Incorporation and Bylaws
Provisions in the Certificate of Incorporation and Bylaws may have the effect of delaying or preventing a change of control or changes in our management. Among other things, the Certificate of Incorporation and Bylaws:
| authorize our board of directors to issue, without stockholder approval, preferred stock with such terms as our board of directors may determine; |
| prohibit action by written consent of our stockholders; |
| prohibit any person other than our board of directors, the chairman of our board of directors, our Chief Executive Officer or holders of at least 25% of the voting power of all then outstanding shares of capital stock of the corporation entitled to vote generally in the election of directors to call a special meeting of our stockholders; and |
| specify advance notice requirements for stockholder proposals and director nominations. |
Our common stock is listed on The New York Stock Exchange under the symbol MX.
Transfer Agent and Registrar
The transfer agent and registrar for our common stock is American Stock Transfer & Trust Company, LLC.
Exhibit 10.30
EXECUTIVE SERVICE AGREEMENT
This Executive Service Agreement (this Agreement), effective as of February 23, 2022 (the Effective Date), is made by and between Shin Young Park (the Executive), on the one hand, and Magnachip Semiconductor Corporation, a Delaware corporation (Parent), and Magnachip Semiconductor, Ltd., a wholly owned subsidiary of Parent (MSK and together with Parent and each of its Affiliates that may engage the Executive from time to time, including any and all successors thereto, the Company), on the other hand.
RECITALS
A. The Company and the Executive desire to enter into this Agreement to assure the Company of the continued exclusive services of the Executive and to set forth the rights and duties of the parties hereto.
B. Except as otherwise set forth herein, this Agreement is intended to supersede any prior agreements or understandings, whether formal or informal, between the Executive and the Company, including the offer letter dated as of January 4, 2019 , by and between the Executive and MSK (the Prior Agreement).
AGREEMENT
NOW, THEREFORE, in consideration of the foregoing and of the respective covenants and agreements set forth below, the parties hereto agree as follows:
1. Certain Definitions.
(a) Affiliate shall mean, with respect to any Person, any other Person directly or indirectly controlling, controlled by or under common control with such Person, where control shall have the meaning given such term under Rule 405 of the Securities Act of 1933, as amended.
(b) Agreement shall have the meaning set forth in the preamble hereto.
(c) Annual Base Salary shall have the meaning set forth in Section 3(a). For the avoidance of doubt, no other compensation (including the Annual Bonus and the Equity Awards) or benefit shall be included in, or be a part of, the Annual Base Salary.
(d) Annual Bonus shall have the meaning set forth in Section 3(b).
(e) Award Agreements shall have the meaning set forth in Section 1(o).
(f) Board shall mean the Board of Directors of the Company.
(g) The Company shall have Cause to terminate the Executives engagement pursuant to Section 4(a)(iii) hereunder upon (i) the Executives conviction of, or a plea of nolo contendere to, a felony or other crime involving moral turpitude (or, in each case, equivalent crimes in a jurisdiction other than the United States), but excluding minor traffic violations; (ii) the Executives commission of fraud, embezzlement or misappropriation of funds; (iii) a breach by the Executive of her fiduciary duty to the Company; (iv) the Executives refusal to fulfill the Executives duties and responsibilities (other than by reason
1
of death or Disability) to the Company; (v) the Executives material violation of any established lawful policy of the Company; (vi) the Executives material breach of any of the terms of any agreement the Executive has with the Company; (vii) the Executives habitual use of illicit drugs or habitual abuse of alcohol that affects her job performance; or (viii) any gross negligence, material misconduct or material wrongful act or omission on the Executives part in connection with the Executives duties and responsibilities to the Company. The Company may terminate the Executives engagement for Cause under this Agreement, following issuance to the Executive of written notice of the circumstances the Company believes constitute Cause, at any time within 90 days after it becomes aware of such circumstances; provided, however, that, if the basis for termination is curable, then the Executive shall have 15 days after receipt of such written notice to cure such basis, and if not cured, the Company may terminate the Executives engagement for Cause at any time within 90 days after the expiration of such cure period. If, within 90 days subsequent to termination of Executives engagement for any reason (other than by the Company for Cause), the Company determines that the Executives engagement could have been terminated for Cause, the Executives engagement will be deemed to have been terminated for Cause for all purposes, and the Executive will be required to disgorge to the Company all amounts received pursuant to this Agreement or otherwise on account of such termination that would not have been payable to the Executive had such termination been by the Company for Cause; provided, however, that the Companys ability to retroactively determine that the Executives engagement could have been terminated for Cause under this sentence will cease upon the occurrence of a Change in Control.
(h) CEO shall mean the Chief Executive Officer of Parent.
(i) Change in Control has the meaning given to such term in the Equity Incentive Plan.
(j) Code shall mean the Internal Revenue Code of 1986, as amended.
(k) Date of Termination shall mean the effective date of termination of Executives engagement, as set forth in Section 4.
(l) Disability shall mean a finding by the Company of the Executives incapacitation through any illness, injury, accident or condition of either a physical or psychological nature that has resulted in her inability to perform the essential functions of her position, even with reasonable accommodations, for 180 calendar days during any period of 365 consecutive calendar days, and such incapacity is expected to continue.
(m) Effective Date shall have the meaning set forth in the preamble hereto.
(n) Executive shall have the meaning set forth in the preamble hereto.
(o) Equity Awards means the equity awards that the Executive may receive subject to the Boards approval and under the terms of the Equity Incentive Plan and standard forms of award agreements under the Equity Incentive Plan (the Award Agreements).
(p) Equity Incentive Plan means, as applicable, the Magnachip Semiconductor Corporation 2020 Equity and Incentive Compensation Plan or any predecessor or successor equity incentive plan of Parent, as amended or amended and restated from time to time.
2
(q) Final Base Salary means the Executives Annual Base Salary as in effect immediately prior to the termination of the Executives engagement (or, if clause (i) or (ii) of the definition of Good Reason is implicated, immediately before any relevant diminution of the Executives Annual Base Salary).
(r) The Executive shall have Good Reason to resign or otherwise terminate her engagement with the Company pursuant to Section 4(a)(v) in the event that any of the following actions are taken by the Company without her consent: (i) if upon or following a Change in Control, a diminution in the Executives Annual Base Salary or Target Annual Bonus opportunity; (ii) if prior to a Change in Control, a diminution in (A) the Executives Annual Base Salary, other than an across the board cumulative reduction of no more than 15% that applies in a similar manner to all similarly-situated members of the senior management of the Company or (B) the Executives Target Annual Bonus opportunity (other than a reduction that occurs as a result of a reduction described in the foregoing clause (A)); (iii) the Companys material breach of any of the material terms of any material agreement between the Executive and the Company; or (iv) a non-temporary relocation of the Executives primary work location by the Company to a location that is more than 35 miles from the Executives principal place of service as of the date hereof (which the parties acknowledge is Seoul, South Korea and/or Cheongju, South Korea) and that increases the Executives one-way commute to work by more than 35 miles. The Executive will not have Good Reason to terminate her engagement and receive payments or benefits under Section 5(b) unless the Executive provides the Board and the CEO with written notice of the circumstances the Executive believes constitute Good Reason within 30 days after the occurrence of such circumstances. If the Company does not cure within 15 days after receipt of such written notice, then the Executive may terminate her engagement for Good Reason at any time within 90 days after the expiration of such cure period. If the Executive terminates her engagement prior to the expiration of the 15-day cure period or more than 90 days after the expiration of the cure period, the Executive will not be treated as having terminated her engagement for Good Reason.
(s) Inventions shall have the meaning set forth in Section 7(c)(i).
(t) Notice of Termination shall have the meaning set forth in Section 4(b).
(u) Parent shall have the meaning set forth in the preamble hereto.
(v) Person shall mean an individual, partnership, corporation, limited liability company, business trust, joint stock company, trust, unincorporated association, joint venture, governmental authority or other entity of whatever nature.
(w) Prior Agreement shall have the meaning set forth in the Recitals.
(x) Proprietary Rights shall have the meaning set forth in Section 7(c)(i).
(y) Target Annual Bonus means the Executives target Annual Bonus, expressed as a percentage of the Annual Base Salary, under the terms of the Companys cash bonus plan as is then in effect.
(z) Term shall have the meaning set forth in Section 2(b).
3
2. Executives Service.
(a) In General. The Company shall engage the Executive, and the Executive shall provide services to the Company, for the period set forth in Section 2(b), in the position(s) set forth in Section 2(c), and upon the other terms and conditions herein provided.
(b) Term. The term of this Agreement (the Term) shall begin on the Effective Date and remain in effect, until terminated as provided in Section 4. Notwithstanding anything herein to the contrary, the Executives engagement with the Company shall be at-will, and the Executive or the Company may terminate the Executives engagement for any reason or no reason at any time, in either case subject to Section 4.
(c) Position and Duties.
(i) During the Term, the Executive shall serve as Chief Financial Officer of Parent and MSK, with responsibilities, duties and authority customary for such position; provided, however, that the Company may alter such responsibilities, duties and authority from time to time. The Executive shall also serve as an officer of other Affiliates of the Company as requested by the Company. Except as otherwise provided herein, the Executive shall not be entitled to any additional compensation for service as a member of the Board or other positions or titles she may hold with any Affiliate of the Company to the extent she is so appointed. The Executive shall report to the CEO or any other officer of the Company as may be designated by the Board or the CEO. The Executive agrees to observe and comply with the Companys rules and policies as adopted from time to time by the Company. The Executive shall devote her full business time, skill, attention and best efforts to the performance of her duties hereunder; provided, however, that the Executive shall be entitled to (A) serve on civic, charitable and religious boards and (B) manage the Executives personal and family investments, in each case, to the extent that such activities do not materially interfere with the performance of the Executives duties and responsibilities hereunder, are not in conflict with the business interests of the Company or its Affiliates, and do not otherwise compete with the business of the Company or its Affiliates.
(ii) The Executive shall be principally based at the Companys offices in Seoul, South Korea or Cheongju, South Korea. The Executive shall perform her duties and responsibilities to the Company at such principal place of service and at such other location(s) to which the Company may reasonably require the Executive to travel for Company business purposes.
3. Compensation and Related Matters.
(a) Annual Base Salary. During the Term, the Executive shall receive a base salary at a rate of Three Hundred Ten Thousand U.S. Dollars (USD 310,000.00) per annum, which shall be paid in accordance with the customary payroll practices of the Company (the Annual Base Salary).
(b) Annual Bonus. With respect to each calendar year that ends during the Term, the Executive shall be eligible to receive an annual cash bonus (the Annual Bonus) under the terms of the Companys cash bonus plan as is then in effect. It is currently intended that the Board will set the Executives target Annual Bonus at 50% of the Executives Annual Base Salary, which target Annual Bonus may be increased by the Board in its discretion.
4
(c) Equity Compensation. While the Executive is engaged to provide services to the Company, the Executive will be eligible to participate in the equity incentive program applicable to the Companys executives. All grants of Equity Awards shall, in all cases, be determined and approved by the Board in its sole discretion. Prior to receiving any Equity Award, the Executive must execute the Award Agreement(s) in the form(s) approved by the Board. Accordingly, the actual terms of any Equity Award will be governed by the Equity Incentive Plan and the actual Award Agreement and documents evidencing the grant of such Equity Award, and not by any other terms set forth herein or otherwise.
(d) Benefits. During the Term, the Executive shall be entitled to participate in the benefit plans, programs and arrangements of the Company now (or, to the extent determined by the Board, hereafter) in effect, in accordance with their terms, including medical and welfare benefits and company automobile, all on the terms applicable to other similarly situated executives of the Company.
(e) Annual Vacation. During the Term, the Executive shall be entitled to paid-time-off (including vacation days) on an annual basis in accordance with the Companys applicable policies and practices. Under the policies applicable to other similarly situated executives of the Company, any unused paid-time-off (including vacation days) shall neither be carried over to the following year nor be compensated for. Any paid-time-off (including vacation days) shall be taken at the reasonable and mutual convenience of the Company and the Executive.
(f) Business Expenses. During the Term, the Company shall reimburse the Executive for all reasonable travel and other business expenses incurred by her in the performance of her duties to the Company, in accordance with the Companys expense reimbursement policies and procedures.
4. Termination. The Executives engagement hereunder may be terminated without any breach of this Agreement only under the following circumstances:
(a) Circumstances.
(i) Death. The Executives engagement hereunder shall terminate upon her death.
(ii) Disability. If the Executive has incurred a Disability, the Company may give the Executive written notice of its intention to terminate the Executives engagement. In that event, the Executives engagement with the Company shall terminate effective on the later of the 30th day after receipt of such notice by the Executive and the date specified in such notice; provided, however, that, if the Executive shall have returned to full-time performance of her duties hereunder within the 30-day period following receipt of such notice and shall have reasonably demonstrated that the Executive is not subject to a Disability, then the Executives engagement shall not be terminated pursuant to this clause (ii).
(iii) Termination with Cause. The Company may terminate the Executives engagement with Cause.
(iv) Termination without Cause. The Company may terminate the Executives engagement without Cause.
5
(v) Resignation with Good Reason. The Executive may resign from her engagement with Good Reason.
(vi) Resignation without Good Reason. The Executive may resign from her engagement without Good Reason upon not less than thirty (30) days advance written notice to the Board and the CEO.
(b) Notice of Termination. Any termination of the Executives engagement with the Company, whether by the Company or the Executive under this Section 4 (other than termination pursuant to Section 4(a)(i)), shall be communicated by written notice to the other party hereto (i) indicating the specific termination provision in this Agreement relied upon, (ii) except with respect to a termination pursuant to Section 4(a)(iv) or (vi), setting forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Executives engagement under the provision so indicated, and (iii) specifying a Date of Termination as provided herein (a Notice of Termination). If the Company delivers a Notice of Termination under Section 4(a)(ii), the Date of Termination shall be at least thirty (30) days following the date of such notice; provided, however, that such notice need not specify a Date of Termination, in which case the Date of Termination shall be determined pursuant to Section 4(a)(ii). If the Company delivers a Notice of Termination under Section 4(a)(iii) or 4(a)(iv), the Date of Termination shall be, in the Companys sole discretion, the date on which the Executive receives such notice or any subsequent date selected by the Company. If the Executive delivers a Notice of Termination under Section 4(a)(v) or 4(a)(vi), the Date of Termination shall be at least thirty (30) days following the date of such notice; provided, however, that the Company may, in its sole discretion, accelerate the Date of Termination to any date that occurs following the Companys receipt of such notice, without changing the characterization of such termination as voluntary, even if such date is prior to the date specified in such notice. The failure by the Company or the Executive to set forth in the Notice of Termination any fact or circumstance that contributes to a showing of Cause or Good Reason shall not waive any right of the Company or the Executive hereunder or preclude the Company or the Executive from asserting such fact or circumstance in enforcing the Companys or the Executives rights hereunder.
(c) Termination and Resignation of All Positions. Upon termination of the Executives engagement for any reason, the Executive agrees to resign, as of the Date of Termination or such other date requested by the Company, from all positions and offices that the Executive then holds with the Company and its Affiliates. In addition, as applicable, if the Executive fails to resign from any such positions or offices, the Company shall be relieved of its obligations under Section 5(b).
5. Company Obligations upon Termination of the Executives Engagement.
(a) In General. Subject to Section 11(a), upon termination of the Executives engagement for any reason, the Executive (or the Executives estate) shall be entitled to receive (i) any amount of the Executives Annual Base Salary earned through the Date of Termination not theretofore paid, (ii) any Annual Bonus for the year prior to the year in which the Date of Termination occurred that was earned but not yet paid, (iii) any expenses owed to the Executive under Section 3(f), and (iv) any vested payment or benefit arising from the Executives participation in, or benefits under, any qualified benefit plans, programs or arrangements under Section 3(d) (other than severance plans, programs or arrangements), which amounts shall be payable in accordance with the terms and conditions of such benefit plans, programs or arrangements including, where applicable, any death and disability
6
benefits (the Accrued Obligations). Notwithstanding anything herein to the contrary, upon a Termination with Cause, and only in the case of such a termination, the Accrued Obligations shall not include the amount set forth in clause (ii) of the preceding sentence or any other amounts or benefits not payable in accordance with the terms and conditions of any benefit plan, program or arrangement.
(b) Termination without Cause or Resignation with Good Reason. Subject to Section 11(a) and subject to the Executives continued compliance with the covenants contained in Sections 6, 7 and 10, if the Company terminates the Executives engagement without Cause pursuant to Section 4(a)(iv) or the Executive resigns from her engagement with Good Reason pursuant to Section 4(a)(v), the Company shall, in addition to the Accrued Obligations:
(i) continue to pay the Final Base Salary in accordance with the Companys customary payroll practices during the period beginning on the Date of Termination and ending on the earlier to occur of (A) the first anniversary of the Date of Termination and (B) the first date that the Executive violates any covenant contained in Section 6 or 7 (the Salary Payment), and if the Date of Termination occurs after June 30 of the calendar year in which the Date of Termination occurs, pay the Executive a prorated portion of the Annual Bonus payable with respect to the calendar year in which such termination occurs (which prorated amount shall equal the amount of the Annual Bonus multiplied by a fraction, (x) the numerator of which equals the number of days that have elapsed between January 1 of such calendar year and the Date of Termination and (y) the denominator of which equals 365), based on actual performance achievement for such year, and payable if and when annual bonuses are paid to other senior executives of the Company with respect to such year (the Pro Rata Bonus, together with the Salary Payment, the Severance Payment); provided, however, that, if the Company terminates the Executives engagement without Cause pursuant to Section 4(a)(iv) or the Executive resigns from her engagement with Good Reason pursuant to Section 4(a)(v), in each case, either (x) during a period of time when the Company is party to a definitive corporate transaction agreement, the consummation of which would result in a Change in Control, or (y) within 18 months following a Change in Control (such a termination a CIC Qualified Termination), then the Severance Payment shall instead equal one and one-half (1.5) times the Final Base Salary, payable over 12 months, in each case so long as the Release (as defined below) has become effective and the Executive has not violated any covenant contained in Section 6 or 7, in which case the Severance Payment shall be forfeited; and
(ii) provide for vesting of any outstanding unvested Equity Awards, as set forth in the Equity Incentive Plan and the applicable Award Agreement(s);
provided, however, that all payments and benefits to be paid or provided pursuant to this Section 5(b) shall commence on the 60th day following the Date of Termination, and, only with respect to any cash payments, the initial installment of such payments shall include a lump-sum payment of all amounts accrued under this Section 5(b) from the Date of Termination through the date of such initial payment.
Notwithstanding anything herein to the contrary, if the Executive breaches any of the covenants contained in Sections 6 and 7, the Company shall have the right to cease providing any payments or benefits under this Section 5(b) and, if requested, the Executive shall repay to the Company within 60 days of such request any previously paid payments or benefits under this Section 5(b); provided that the foregoing shall not apply unless the Company provides the Executive with written notice of the circumstances it believes constitutes a breach of such covenants within 90 days after it becomes aware of such circumstances; provided further that, if the basis for the alleged breach is curable, then the Executive shall have 15 days after receipt of such written notice to cure such basis.
7
Payment of the amounts and benefits under this Section 5(b) is in lieu of any other severance or separation pay payable to the Executive whether under any previous agreement, offer letter or severance program, plan or policy, applicable law (including the laws of the Republic of Korea) or other statute, or otherwise.
(c) Release. Notwithstanding anything herein to the contrary, the amounts payable and benefits to be provided to the Executive under Section 5(b), other than the Accrued Obligations, shall be contingent upon and subject to the Executives (or the Executives estates, if applicable) execution and non-revocation of a general waiver and release of claims agreement generally consistent with the form attached as Exhibit A hereto (as appropriately modified to comply with applicable law, the Release) (and the expiration of any applicable revocation period), on or prior to the 60th day following the Date of Termination.
(d) Survival. The obligations of any of the parties under this Agreement which by their nature may require either partial or total performance after the termination of the Term or this Agreement (including those under Sections 6, 7, 8, 9 and 10) and Sections 11, 12, 14, 15, 22, 23, 24 and 25 will survive any termination of this Agreement.
6. Non-Competition; Non-Solicitation; Non-Hire.
(a) To the fullest extent permitted by applicable law, the Executive agrees that during the Executives engagement with the Company, and for the 12-month period following termination of the Executives engagement for any reason, the Executive will not, directly or indirectly, have any equity or equity-based interest, or work or otherwise provide services as an employee, contractor, officer, owner, consultant, partner, director or otherwise, in any business anywhere in the world that competes with any of the businesses of the Company. Notwithstanding the foregoing, the Executive shall be permitted to acquire a passive stock or equity interest in such a business, provided that the stock or other equity interest acquired is not more than five percent (5%) of the outstanding interest in such business. Notwithstanding anything herein to the contrary, if prior to the expiration of the aforementioned 12-month period the Executive enters into any agreement that obligates the Executive to provide any form of services to the Company, then such 12-month period shall commence on the date that the Executives ceases to provide services under such agreement.
(b) To the fullest extent permitted by applicable law, the Executive agrees that during the Executives engagement with the Company, and for the 12-month period following termination of the Executives engagement for any reason, the Executive will not, directly or indirectly, on the Executives own behalf or on behalf of another (i) solicit, induce or attempt to solicit or induce any officer, director, employee or consultant of the Company to terminate their relationship with or leave the Company, or in any way interfere with the relationship between the Company, on the one hand, and any officer, director, employee or consultant thereof, on the other hand, (ii) hire (or other similar arrangement) any Person (in any capacity whether as an officer, director, employee or consultant) who is, or at any time in the 12 months preceding the Date of Termination was, an officer, director, employee or consultant of the Company or (iii) induce or attempt to induce any customer, supplier, prospect, licensee or other business relation of the Company to cease doing business with the Company, or in any way interfere with the relationship between any such customer, supplier, prospect, licensee or business relation, on the one hand, and the Company, on the other hand.
8
(c) In the event that the terms of this Section 6 shall be determined by any court of competent jurisdiction to be unenforceable by reason of its extending for too great a period of time or over too great a geographical area or by reason of its being too extensive in any other respect, it will be interpreted to extend only over the maximum period of time for which it may be enforceable, over the maximum geographical area as to which it may be enforceable, or to the maximum extent in all other respects as to which it may be enforceable, all as determined by such court in such action. The Executive hereby acknowledges that the terms of this Section 6 are reasonable in terms of duration, scope and area restrictions and are necessary to protect the goodwill of the Company. The Executive hereby authorizes the Company to inform any future employer or prospective employer of the existence and terms of Sections 6 and 7 without liability for interference with the Executives employment or prospective employment.
7. Non-Disclosure of Confidential Information; Non-Disparagement; Intellectual Property.
(a) Non-Disclosure of Confidential Information; Return of Property. The Executive recognizes and acknowledges that she has access to confidential information and/or has had or will have material contact with the Companys customers, suppliers, licensees, representatives, agents, partners, licensors or business relations. The Executive agrees that during her engagement and in perpetuity thereafter, the Executive shall maintain in confidence and shall not directly, indirectly or otherwise, use, disseminate, disclose or publish, or use for the Executives benefit or the benefit of any Person, any confidential or proprietary information or trade secrets of or relating to the Company, including information with respect to the Companys operations, processes, products, inventions, business practices, finances, principals, vendors, suppliers, customers, potential customers, marketing methods, costs, prices, contractual relationships, regulatory status, compensation paid to employees or other terms of employment, or deliver to any Person any document, record, notebook, computer program or similar repository of or containing any such confidential or proprietary information or trade secrets. Upon termination of the Executives engagement for any reason, the Executive shall promptly deliver to the Company all correspondence, drawings, manuals, letters, notes, notebooks, reports, programs, plans, proposals, financial documents or any other documents concerning the Companys customers, business plans, marketing strategies, products or processes. The Executive may respond to a lawful and valid subpoena or other legal process but shall give the Company the earliest possible notice thereof, shall, as much in advance of the return date as possible, make available to the Company and its counsel the documents and other information sought and, if requested by the Company, shall reasonably assist such counsel in resisting or otherwise responding to such process.
(b) Non-Disparagement. The Executive shall not, at any time during her engagement and in perpetuity thereafter, directly or indirectly, knowingly disparage, criticize or otherwise make derogatory statements regarding the Company, or any of its successors, directors or officers. The foregoing shall not be violated by the Executives truthful responses to legal process or inquiry by a governmental authority.
9
(c) Intellectual Property Rights.
(i) The Executive agrees that the results and proceeds of the Executives services for the Company (including any trade secrets, products, services, processes, know-how, designs, developments, innovations, analyses, drawings, reports, techniques, formulas, methods, developmental or experimental work, improvements, discoveries, inventions, ideas, source and object codes, programs, matters of a literary, musical, dramatic or otherwise creative nature, writings and other works of authorship) resulting from services performed for the Company and any works in progress, whether or not patentable or registrable under copyright or similar statutes, that were made, developed, conceived or reduced to practice or learned by the Executive, either alone or jointly with others (collectively, Inventions), shall be works-made-for-hire and the Company (or, if applicable or as directed by the Company) shall be deemed the sole owner throughout the universe of any and all trade secret, patent, copyright and other intellectual property rights (collectively, Proprietary Rights) of whatsoever nature therein, whether or not now or hereafter known, existing, contemplated, recognized or developed, with the right to use the same in perpetuity in any manner the Company determines in its sole discretion, without any further payment to the Executive whatsoever. If, for any reason, any of such results and proceeds shall not legally be a work-made-for-hire and/or there are any Proprietary Rights which do not accrue to the Company under the immediately preceding sentence, then the Executive hereby irrevocably assigns and agrees to assign any and all of the Executives right, title and interest thereto, including any and all Proprietary Rights of whatsoever nature therein, whether or not now or hereafter known, existing, contemplated, recognized or developed, to the Company (or, if applicable or as directed by the Company), and the Company or such Affiliates shall have the right to use the same in perpetuity throughout the universe in any manner determined by the Company or such Affiliates without any further payment to the Executive whatsoever. As to any Invention that the Executive is required to assign, the Executive shall promptly and fully disclose to the Company all information known to the Executive concerning such Invention. The Executive hereby waives and quitclaims to the Company any and all claims, of any nature whatsoever, that the Executive now or may hereafter have for infringement of any Proprietary Rights assigned hereunder to the Company.
(ii) The Executive agrees that, from time to time, as may be requested by the Company and at the Companys sole cost and expense, the Executive shall do any and all things that the Company may reasonably deem useful or desirable to establish or document the Companys exclusive ownership throughout the United States of America or any other country of any and all Proprietary Rights in any such Inventions, including the execution of appropriate copyright and/or patent applications or assignments. To the extent the Executive has any Proprietary Rights in the Inventions that cannot be assigned in the manner described above, the Executive unconditionally and irrevocably waives the enforcement of such Proprietary Rights. This Section 7(c)(ii) is subject to and shall not be deemed to limit, restrict or constitute any waiver by the Company of any Proprietary Rights of ownership to which the Company may be entitled by operation of law by virtue of the Executives engagement with the Company. The Executive further agrees that, from time to time, as may be requested by the Company and at the Companys sole cost and expense, the Executive shall assist the Company in every proper and lawful way to obtain and from time to time enforce Proprietary Rights relating to Inventions in any and all countries. To this end, the Executive shall execute, verify and deliver such documents and perform such other acts (including appearances as a witness) as the Company may reasonably request for use in applying for, obtaining, perfecting, evidencing, sustaining and enforcing such Proprietary Rights and the
10
assignment thereof. In addition, the Executive shall execute, verify and deliver assignments of such Proprietary Rights to the Company or its designees. The Executives obligation to assist the Company with respect to Proprietary Rights relating to such Inventions in any and all countries shall continue beyond the termination of the Executives engagement with the Company.
(d) Protected Disclosures.
(i) Nothing in this Agreement will preclude, prohibit or restrict the Executive from (A) communicating with, any federal, state or local administrative or regulatory agency or authority, including the Securities and Exchange Commission (the SEC); (B) participating or cooperating in any investigation conducted by any governmental agency or authority; or (C) filing a charge of discrimination with the United States Equal Employment Opportunity Commission or any other federal state or local administrative agency or regulatory authority.
(ii) Nothing in this Agreement, or any other agreement between the parties, prohibits or is intended in any manner to prohibit, the Executive from (A) reporting a possible violation of federal or other applicable law or regulation to any governmental agency or entity, including the Department of Justice, the SEC, the U.S. Congress and any governmental agency Inspector General, or (B) making other disclosures that are protected under whistleblower provisions of federal law or regulation. This Agreement does not limit the Executives right to receive an award (including a monetary reward) for information provided to the SEC. The Executive does not need the prior authorization of anyone at the Company to make any such reports or disclosures, and the Executive is not required to notify the Company that the Executive has made such reports or disclosures.
(iii) Nothing in this Agreement or any other agreement or policy of the Company is intended to interfere with or restrain the immunity provided under 18 U.S.C. §1833(b). The Executive cannot be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made (A) (1) in confidence to federal, state or local government officials, directly or indirectly, or to an attorney, and (2) for the purpose of reporting or investigating a suspected violation of law; (B) in a complaint or other document filed in a lawsuit or other proceeding, if filed under seal; or (C) in connection with a lawsuit alleging retaliation for reporting a suspected violation of law, if filed under seal and does not disclose the trade secret, except pursuant to a court order.
(iv) The foregoing provisions regarding protected disclosures are intended to comply with all applicable laws. If any laws are adopted, amended or repealed after the execution of this Agreement, this Section 7(e) shall be deemed to be amended to reflect the same.
8. Injunctive Relief. The Executive recognizes and acknowledges that a breach of any of the covenants contained in Sections 6 and 7 will cause irreparable damage to the Company and its goodwill, the exact amount of which will be difficult or impossible to ascertain, and that the remedies at law for any such breach will be inadequate. Accordingly, the Executive agrees that in the event of a breach or threatened breach of any of the covenants contained in Sections 6 and 7, in addition to any other remedy that may be available at law or in equity, the Company will be entitled to specific performance and injunctive relief (without posting a bond). In the event of any breach or violation by the Executive of any of the covenants contained in Sections 6 and 7, the time period of such covenant with respect to the Executive shall, to the fullest extent permitted by law, be tolled until such breach or violation is resolved.
11
9. Indemnification. During the Executives engagement as a director or officer (or both) of Parent, and at all times thereafter during which the Executive may be subject to liability in connection with the Executives performance of her duties as a director or officer (or both) of Parent, the Executive shall be entitled to the protection set forth in the Indemnification Agreement between the Executive and the Company to be entered into on or about the date hereof, in addition to the protection of any insurance policies the Company may elect to maintain generally for the benefit of its directors and officers against all costs, charges, and expenses incurred or sustained by her in connection with any action, suit or proceeding to which she may be made a party by reason of her being or having been a director, officer or employee of the Company, as well as any rights the Executive may have under the Companys articles of incorporation and bylaws (in each case, other than any dispute, claim or controversy arising under or relating to this Agreement or otherwise arising under or relating to the Executives engagement, equity ownership or compensation). Notwithstanding anything herein to the contrary, the Executives rights under this Section 9 shall survive the termination or expiration of this Agreement for any reason.
10. Cooperation. The Executive agrees that, subject to the Executives reasonable availability, during and after the Executives engagement with the Company, and without the necessity of the Company obtaining a subpoena or court order, the Executive shall provide reasonable cooperation in connection with any suit, action or proceeding (or any appeal from any suit, action or proceeding), and any investigation and/or defense of any claims asserted against the Company Releasees (as defined in the Release), which relates to events occurring during the Executives engagement (including furnishing relevant information and materials to the Company or its designee and/or providing testimony at depositions and at trial); provided that the Company shall reimburse the Executive for reasonable out-of-pocket expenses the Executive incurs that are associated with any such cooperation; provided further that any such cooperation occurring after the termination of the Executives engagement shall be scheduled to the extent reasonably practicable so as not to unreasonably interfere with the Executives business or personal affairs. Notwithstanding anything herein to the contrary, the preceding cooperation covenant shall not apply to any suit, action, proceeding, investigation, defense or claim that arises out of or relates to a dispute between the Executive and any of the Company Releasees.
11. Section 409A of the Code.
(a) General. The parties hereto acknowledge and agree that, to the extent applicable, this Agreement shall be interpreted in accordance with, and incorporate the terms and conditions required by, Section 409A of the Code and the Department of Treasury Regulations and other interpretive guidance issued thereunder, including any such regulations or other guidance that may be issued after the Effective Date (Section 409A). Notwithstanding anything herein to the contrary, in the event that the Company determines that any amounts payable hereunder will be taxable currently to the Executive under Section 409A(a)(1)(A) of the Code and related Department of Treasury guidance, the Company and the Executive shall cooperate in good faith to (i) adopt such amendments to this Agreement and appropriate policies and procedures, including amendments and policies with retroactive effect, that they mutually determine to be necessary or appropriate to preserve the intended tax treatment of the benefits provided by this Agreement, to preserve the economic benefits of this Agreement, and to avoid less-favorable accounting or tax
12
consequences for the Company, and/or (ii) take such other actions as mutually determined to be necessary or appropriate to exempt the amounts payable hereunder from Section 409A or to comply with the requirements of Section 409A and thereby avoid the application of penalty taxes thereunder; provided, however, that this Section 11(a) does not create an obligation on the part of the Company to modify this Agreement and does not guarantee that the amounts payable hereunder will not be subject to interest or penalties under Section 409A, and in no event whatsoever shall the Company be liable for any additional tax, interest or penalties that may be imposed on the Executive as a result of Section 409A or any damages for failing to comply with Section 409A.
(b) Separation from Service under Section 409A. To the extent Section 409A is applicable, notwithstanding anything herein to the contrary: (i) no amount shall be payable pursuant to Section 5(a) or 5(b) unless the termination of the Executives engagement constitutes a separation from service within the meaning of Section 1.409A-1(h) of the Department of Treasury Regulations; (ii) if the Executive is deemed at the time of her separation from service to be a specified employee for purposes of Section 409A(a)(2)(B)(i) of the Code, to the extent that delayed commencement of any portion of the termination benefits to which the Executive is entitled under this Agreement (after taking into account all exclusions applicable to such termination benefits under Section 409A), including any portion of the additional compensation awarded pursuant to Section 5(a) or 5(b), is required in order to avoid a prohibited distribution under Section 409A(a)(2)(B)(i) of the Code, such portion of the Executives termination benefits shall not be provided to the Executive prior to the earlier of (A) the expiration of the six-month period measured from the date of the Executives separation from service with the Company (as such term is defined in the Department of Treasury Regulations issued under Section 409A) and (B) the date of the Executives death; provided that, upon the earlier of such dates, all payments deferred pursuant to this clause (ii) shall be paid to the Executive in a lump sum, and any remaining payments due under this Agreement shall be paid as otherwise provided herein; (iii) the determination of whether the Executive is a specified employee for purposes of Section 409A(a)(2)(B)(i) of the Code as of the time of her separation from service shall be made by the Company in accordance with the terms of Section 409A of the Code and applicable guidance thereunder (including Section 1.409A-1(i) of the Department of Treasury Regulations and any successor provision thereto); (iv) for purposes of Section 409A of the Code, the Executives right to receive installment payments pursuant to Section 5 shall be treated as a right to receive a series of separate and distinct payments; (v) if the sixty day period following the Date of Termination ends in the calendar year following the year that includes the Date of Termination, then payment of any amount that is conditioned upon the execution of the Release and is subject to Section 409A shall not be paid until the first day of the calendar year following the year that includes the Date of Termination, regardless of when the Release is signed; and (vi) to the extent that any reimbursement of expenses or in-kind benefits constitutes deferred compensation under Section 409A, such reimbursement or benefit shall be provided no later than December 31 of the year following the year in which the expense was incurred. The amount of expenses reimbursed in one year shall not affect the amount eligible for reimbursement in any subsequent year. The amount of any in-kind benefits provided in one year shall not affect the amount of in-kind benefits provided in any other year.
13
12. Section 280G of the Code.
(a) If there is a change of ownership or effective control or change in the ownership of a substantial portion of the assets of a corporation (within the meaning of Section 280G of the Code) and any payment or benefit (including payments and benefits pursuant to this Agreement) that the Executive would receive from the Company or otherwise (Transaction Payment) would (i) constitute a parachute payment within the meaning of Section 280G of the Internal Revenue Code of 1986, and (ii) but for this sentence, be subject to the excise tax imposed by Section 4999 of the Code (the Excise Tax), then the Company shall cause to be determined, before any amounts of the Transaction Payment are paid to the Executive, which of the following two alternative forms of payment would result in the Executives receipt, on an after-tax basis, of the greater amount of the Transaction Payment notwithstanding that all or some portion of the Transaction Payment may be subject to the Excise Tax: (1) payment in full of the entire amount of the Transaction Payment (a Full Payment) or (2) payment of only a part of the Transaction Payment so that the Executive receives the largest payment possible without the imposition of the Excise Tax (a Reduced Payment). For purposes of determining whether to make a Full Payment or a Reduced Payment, the Company shall cause to be taken into account all applicable federal, state and local income taxes and the Excise Tax (all computed at the highest applicable marginal rate, net of the maximum reduction in federal income taxes which could be obtained from a deduction of such state and local taxes). If a Reduced Payment is made, the reduction in payments and/or benefits will occur in the following order: (1) first, reduction of cash payments, in reverse order of scheduled payment date (or if necessary, to zero), (2) then, reduction of non-cash and non-equity benefits provided to the Executive, on a pro rata basis (or if necessary, to zero), and (3) then, cancellation of the acceleration of vesting of equity award compensation in the reverse order of the date of grant of the Executives equity awards.
(b) Unless the Executive and the Company otherwise agree in writing, any determination required under this section shall be made in writing by the Companys independent public accountants (the Accountants), whose determination shall be conclusive and binding upon the Executive and the Company for all purposes. For purposes of making the calculations required by this section, the Accountants may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of Sections 280G and 4999 of the Code. The Accountants shall provide detailed supporting calculations to the Company and the Executive as requested by the Company or the Executive. The Executive and the Company shall furnish to the Accountants such information and documents as the Accountants may reasonably request in order to make a determination under this section. The Company shall bear all costs the Accountants may reasonably incur in connection with any calculations contemplated by this Section 12(b).
13. Assignment and Successors. The Company may assign its rights and obligations under this Agreement to any entity, including any successor to all or substantially all the assets of the Company, by merger or otherwise, and may assign or encumber this Agreement and its rights hereunder as security for indebtedness of the Company and its Affiliates. The Executive may not assign her rights or obligations under this Agreement to any individual or entity. This Agreement shall be binding upon and inure to the benefit of the Company and the Executive and their respective successors, assigns, personnel, legal representatives, executors, administrators, heirs, distributees, devisees and legatees, as applicable. In the event of the Executives death following a termination of her engagement, all unpaid amounts otherwise due to the Executive (including under Section 5) shall be paid to her estate.
14
14. Governing Law. This Agreement shall be governed, construed, interpreted, and enforced in accordance with the substantive laws of the State of Delaware, without reference to the principles of conflicts of law of Delaware or any other jurisdiction, and where applicable, the laws of the United States.
15. Validity. The invalidity or unenforceability of any provision or provisions of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement, which shall remain in full force and effect.
16. Notices. Any notice, request, claim, demand, document, and other communication hereunder to any party hereto shall be effective upon receipt (or refusal of receipt) and shall be in writing and delivered personally or sent by telex, telecopy, email or sent by nationally recognized overnight courier or certified or registered mail, postage prepaid, to the following address (or at any other address as any party hereto shall have specified by notice in writing to the other party hereto):
(a) If to the Company, to it at its current executive offices, Attn: Chief Executive Officer.
(b) If to the Executive, at her most recent address on the payroll records of the Company.
17. Counterparts. This Agreement may be executed in several counterparts, each of which shall be deemed to be an original, but all of which together will constitute one and the same Agreement.
18. Entire Agreement. The terms of this Agreement (together with the Indemnification Agreement between Parent and the Executive, any pre-invention assignment agreements with the Company and any other agreements and instruments contemplated hereby or referred to herein) are intended by the parties hereto to be the final expression of their agreement with respect to the Executives engagement with the Company and to supersede any and all prior agreements (including the Prior Agreement), communications expressing the Companys offer to the Executive, severance agreements and similar agreements, plans, provisions, understandings or arrangements, whether written or oral, and all such prior agreements, plans, provisions, understandings or arrangements shall be null and void in their entirety and of no further force or effect as of the Effective Date. The parties hereto further intend that this Agreement shall constitute the complete and exclusive statement of its terms and that no extrinsic evidence whatsoever may be introduced in any judicial, administrative or other legal proceeding to vary the terms of this Agreement.
19. Amendments; Waivers. This Agreement may not be modified, amended or terminated except by an instrument in writing signed by the Executive and a duly authorized officer of the Company that expressly identifies the amended provision of this Agreement. By an instrument in writing similarly executed and similarly identifying the waived compliance, the Executive or a duly authorized officer of the Company may waive compliance by the other party or parties with any provision of this Agreement that such other party was or is obligated to comply with or perform; provided, however, that such waiver shall not operate as a waiver of, or estoppel with respect to, any other or subsequent failure to comply or perform. No failure to exercise and no delay in exercising any right, remedy or power hereunder shall preclude any other or further exercise of any other right, remedy or power provided herein or by law or in equity.
15
20. No Inconsistent Actions. The parties hereto shall not voluntarily undertake or fail to undertake any action or course of action inconsistent with the provisions or essential intent of this Agreement. Furthermore, it is the intent of the parties hereto to act in a fair and reasonable manner with respect to the interpretation and application of the provisions of this Agreement.
21. Construction. This Agreement shall be deemed drafted equally by both of the parties hereto. Its language shall be construed as a whole and according to its fair meaning. Any presumption or principle that the language is to be construed against any party shall not apply. The headings in this Agreement are only for convenience and are not intended to affect construction or interpretation. Any references to paragraphs, subparagraphs, sections or subsections are to those parts of this Agreement, unless the context clearly indicates to the contrary. Also, unless the context clearly indicates to the contrary: (a) the plural includes the singular, and the singular includes the plural; (b) and and or can each used both conjunctively and disjunctively; (c) any, all, each, or every means any and all, and each and every; (d) includes and including are each without limitation; and (e) herein, hereof, hereunder, and other similar compounds of the word here refer to the entire Agreement and not to any particular paragraph, subparagraph, section or subsection.
22. Dispute Resolution. The parties agree that any suit, action or proceeding brought by or against such party in connection with this Agreement shall be brought exclusively in the United States District Court for the District of Delaware to the extent that federal jurisdiction exists, and in the Delaware Chancery Court to the extent that federal jurisdiction does not exist. Each party expressly and irrevocably consents and submits to the jurisdiction and venue of each such court in connection with any such legal proceeding, including to enforce any settlement, order or award, and such party agrees to accept service of process by the other party or any of its agents in connection with any such proceeding. EACH PARTY HEREBY IRREVOCABLY WAIVES ALL RIGHT TO A TRIAL BY JURY IN ANY SUIT, ACTION OR OTHER PROCEEDING INSTITUTED BY OR AGAINST SUCH PARTY IN RESPECT OF ITS RIGHTS OR OBLIGATIONS HEREUNDER.
23. Enforcement. If any provision of this Agreement is held to be illegal, invalid or unenforceable under present or future laws effective during the term of this Agreement, such provision shall be fully severable, this Agreement shall be construed and enforced as if such illegal, invalid or unenforceable provision were never a part of this Agreement, and the remaining provisions of this Agreement shall remain in full force and effect and shall not be affected by the illegal, invalid or unenforceable provision or by its severance from this Agreement. Furthermore, in lieu of such illegal, invalid or unenforceable provision, there shall be added automatically as part of this Agreement a provision as similar in terms to such illegal, invalid or unenforceable provision as may be possible and be legal, valid and enforceable.
24. Withholding. The Company shall be entitled to withhold from any amounts payable under this Agreement any federal, state, local, and foreign withholding and other taxes and charges that the Company is required to withhold. The Company shall be entitled to rely on an opinion of counsel if any questions as to the amount or requirement of withholding shall arise.
16
25. Clawback. To the extent required by applicable law (including Section 304 of the Sarbanes-Oxley Act and Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act) and/or the rules and regulations of any securities exchange or inter-dealer quotation service on which equity of the Company or Parent is listed or quoted, or if so required pursuant to a written policy adopted by the Company or Parent, payments under this Agreement or in respect of Company or Parent equity incentive awards shall be subject (including on a retroactive basis) to clawback, forfeiture or similar requirements (and such requirements shall be deemed incorporated by reference into this Agreement and all agreements governing the terms of Company or Parent incentive equity compensation).
26. Other Benefit Plans. No payment under this Agreement shall be taken into account in determining any benefits under any pension, retirement, profit sharing, group insurance or other benefit plan of the Company except as expressly required otherwise by law or the terms of such plan.
27. Executives Representations. The Executive represents, warrants and covenants that (i) that she has read and understands this Agreement, is fully aware of its legal effect, has not acted in reliance upon any representations or promises made by the Company other than those contained in writing herein, and has entered into this Agreement freely based on her own judgment, (ii) Executive has the full right, authority and capacity to enter into this Agreement and perform Executives obligations hereunder, (iii) Executive is not bound by any agreement that conflicts with or prevents or restricts the full performance of Executives duties and obligations to the Company hereunder during or after the Term, (iv) the execution and delivery of this Agreement shall not result in any breach or violation of, or a default under, any existing obligation, commitment or agreement to which Executive is subject, and (v) the Executive shall keep all terms of this Agreement confidential, except with respect to disclosure to the Executives spouse, accountants or attorneys, each of whom shall agree to keep all terms of this Agreement confidential.
28. Equity Ownership. The Executive will be subject to such stock ownership guidelines and holding requirements as may be implemented by the Board from time to time.
[signature page follows]
17
Shin Young Park
The parties have executed this Agreement as of the date first written above.
MAGNACHIP SEMICONDUCTOR, LTD. | ||
By: | /s/ Young-Joon Kim | |
Name: Young-Joon Kim | ||
Title: Representative Director | ||
MAGNACHIP SEMICONDUCTOR CORPORATION | ||
By: | /s/ Young-Joon Kim | |
Name: Young-Joon Kim | ||
Title: Chief Executive Officer | ||
EXECUTIVE | ||
/s/ Shin Young Park Shin Young Park |
Shin Young Park
EXHIBIT A
FORM OF RELEASE
As used in this Release of Claims (this Release), the term claims will include all claims, covenants, warranties, promises, undertakings, actions, suits, causes of action, proceedings, obligations, debts, accounts, attorneys fees, judgments, losses, and liabilities, of whatsoever kind or nature, in law, in equity or otherwise. Capitalized terms used but not defined in this Release will have the meanings given to them in the Executive Service Agreement (the Service Agreement), effective as of February 23, 2022, by and between Magnachip Semiconductor Corporation, a Delaware corporation (Parent), and Magnachip Semiconductor, Ltd., a wholly owned subsidiary of Parent (MSK), on the one hand, and Shin Young Park.
For and in consideration of the payments and benefits under Section 5(b) of the Service Agreement, and other good and valuable consideration, I, for and on behalf of myself and my executors, heirs, administrators, representatives and assigns, hereby agree to release and forever discharge the Company, Parent and all of their respective predecessors, successors, and past, current, and future parent entities, affiliates, subsidiary entities, investors, directors, shareholders, members, officers, general or limited partners, employees, attorneys, agents, and representatives, and the benefit plans in which I am or have been a participant by virtue of my engagement with or service to the Company (collectively, the Company Releasees), from any and all claims that I have or may have had against the Company Releasees based on any events or circumstances arising or occurring on or prior to the date hereof and arising directly or indirectly out of, relating to, or in any other way involving in any manner whatsoever my engagement with or service to the Company or the termination thereof, including any and all claims arising under national, federal, provincial, state or local laws relating to employment, including claims of wrongful discharge, breach of express or implied contract, fraud, misrepresentation, defamation, intentional infliction of emotional distress or liability in tort, and claims of any kind that may be brought in any court or administrative agency, and any related claims for attorneys fees and costs, including claims under Title VII of the Civil Rights Act of 1964, as amended, 42 U.S.C. Section 2000, et seq.; the Americans with Disabilities Act, as amended, 42 U.S.C. § 12101 et seq.; the Rehabilitation Act of 1973, as amended, 29 U.S.C. § 701 et seq.; the Civil Rights Act of 1866, and the Civil Rights Act of 1991; 42 U.S.C. Section 1981, et seq.; the Age Discrimination in Employment Act, as amended, 29 U.S.C. Section 621, et seq. (the ADEA); the Equal Pay Act, as amended, 29 U.S.C. Section 206(d); regulations of the Office of Federal Contract Compliance, 41 C.F.R. Section 60, et seq.; the Family and Medical Leave Act, as amended, 29 U.S.C. § 2601 et seq.; the Fair Labor Standards Act of 1938, as amended, 29 U.S.C. § 201 et seq.; the Employee Retirement Income Security Act, as amended, 29 U.S.C. § 1001 et seq.; and any similar national, provincial, state or local laws of the United States, the Republic of Korea or any other jurisdiction. I agree further that this Release may be pleaded as a full defense to any action, suit, arbitration or other proceeding covered by the terms hereof that is or may be initiated, prosecuted, or maintained by me or my descendants, dependents, heirs, executors, administrators or assigns. By signing this Release, I acknowledge that I intend to waive and release all rights known or unknown that I may have against the Company Releasees under these and any other laws.
I acknowledge and agree that, as of the date I execute this Release, I have no knowledge of any facts or circumstances that give rise or could give rise to any claims under any of the laws listed in the preceding paragraph and that I have not filed any claim against any of the Company Releasees before any local, state, federal or foreign agency, court, arbitrator, mediator, arbitration or mediation panel or other body (each individually, a Proceeding). I (i) acknowledge that I will not initiate or cause to be initiated on my behalf any Proceeding and will not participate in any Proceeding, in each case, except as required by law; and (ii) waive any right that I may have to benefit in any manner from any relief (whether monetary or otherwise) arising out of any Proceeding, except where otherwise provided by law, including any Proceeding conducted by the Equal Employment Opportunity Commission (EEOC). Further, I understand that, by executing this Release, I will be limiting the availability of certain remedies that I may have against the Company and limiting also my ability to pursue certain claims against the Company Releasees.
By executing this Release, I specifically release all claims relating to my engagement with and service to the Company, and its termination, under ADEA, a federal statute that, among other things, prohibits discrimination on the basis of age in engagement and benefit plans.
Notwithstanding the generality of the foregoing, I do not release (i) claims to receive payments and benefits under Section 5(b) of the Service Agreement in accordance with the terms of the Service Agreement, (ii) claims for indemnification arising under any applicable indemnification obligation of the Company, (iii) any vested rights I may have under any qualified benefit plans, programs or policies of the Company, or (iv) claims that cannot be waived by law. Further, nothing in this Release shall prevent me from (a) initiating or causing to be initiated on my behalf any claim against the Company before any local, state or federal agency, court or other body challenging the validity of the waiver of my claims under the ADEA (but no other portion of such waiver); or (b) initiating or participating in an investigation or proceeding conducted by the EEOC.
I understand that nothing in this Agreement will preclude, prohibit or restrict me from (i) communicating with, any federal, state or local administrative or regulatory agency or authority, including the Securities and Exchange Commission (the SEC); (ii) participating or cooperating in any investigation conducted by any governmental agency or authority; or (iii) filing a charge of discrimination with the EEOC or any other federal state or local administrative agency or regulatory authority.
Nothing in this Agreement, or any other agreement with the Company, prohibits or is intended in any manner to prohibit, me from (i) reporting a possible violation of federal or other applicable law or regulation to any governmental agency or entity, including the Department of Justice, the SEC, the U.S. Congress and any governmental agency Inspector General, or (ii) making other disclosures that are protected under whistleblower provisions of federal law or regulation. This Agreement does not limit my right to receive an award (including a monetary reward) for information provided to the SEC. I do not need the prior authorization of anyone at the Company to make any such reports or disclosures, and I am not required to notify the Company that I have made such reports or disclosures.
Nothing in this Agreement or any other agreement or policy of the Company is intended to interfere with or restrain the immunity provided under 18 U.S.C. §1833(b). I cannot be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made (i) (A) in confidence to federal, state or local government officials, directly or indirectly, or to an attorney, and (B) for the purpose of reporting or investigating a suspected violation of law; (ii) in a complaint or other document filed in a lawsuit or other proceeding, if filed under seal; or (iii) in connection with a lawsuit alleging retaliation for reporting a suspected violation of law, if filed under seal and does not disclose the trade secret, except pursuant to a court order.
I acknowledge that I have been given at least 21 days in which to consider this Release. I acknowledge further that the Company has advised me to consult with an attorney of my choice before signing this Release, and I have had sufficient time to consider the terms of this Release. I represent and acknowledge that if I execute this Release before 21 days have elapsed, I do so knowingly, voluntarily, and upon the advice and with the approval of my legal counsel (if any), and that I voluntarily waive any remaining consideration period.
I understand that after executing this Release, I have the right to revoke it within seven days after its execution. I understand that this Release will not become effective and enforceable unless the seven-day revocation period passes and I do not revoke the Release in writing. I understand that this Release may not be revoked after the seven-day revocation period has passed. I understand also that any revocation of this Release must be made in writing and delivered to the Company at its principal place of business within the seven-day period.
This Release will become effective, irrevocable, and binding on the eighth day after its execution, so long as I have not timely revoked it as set forth above. I understand and acknowledge that I will not be entitled to payments or benefits under Section 5(b) of the Service Agreement unless this Release is effective on or before the date that is 60 days following the Date of Termination (as defined in the Service Agreement).
I hereby agree to waive any and all claims to re-engagement with the Company and affirmatively agree not to seek further engagement with the Company.
The provisions of this Release will be binding upon my heirs, executors, administrators, legal representatives, and assigns. If any provision of this Release will be held by any court of competent jurisdiction to be illegal, void or unenforceable, such provision will be of no force or effect. The illegality or unenforceability of such provision, however, will have no effect upon and will not impair the enforceability of any other provision of this Release.
This Release will be governed in accordance with the laws of the State of Delaware, without reference to the principles of conflicts of law. Any dispute or claim arising out of or relating to this Release or claim of breach hereof will be brought exclusively in the United States District Court for the District of Delaware to the extent that federal jurisdiction exists, and in the Delaware Chancery Court to the extent that federal jurisdiction does not exist. By execution of this Release, I am waiving any right to trial by jury in connection with any suit, action or proceeding under or in connection with this Release.
Shin Young Park |
|
Date |
Exhibit 21.1
SUBSIDIARIES OF MAGNACHIP SEMICONDUCTOR CORPORATION
Subsidiary |
Jurisdiction of Incorporation | |
MagnaChip Semiconductor S.A. | Luxembourg | |
MagnaChip Semiconductor B.V. | The Netherlands | |
Magnachip Semiconductor, Ltd. | Korea | |
MagnaChip Semiconductor SA Holdings LLC | Delaware | |
MagnaChip Semiconductor Limited | Taiwan | |
Magnachip Semiconductor Limited | Hong Kong SAR | |
Magnachip Semiconductor Inc. | Japan | |
MagnaChip Semiconductor Holding Company Limited | British Virgin Islands | |
Magnachip Semiconductor (Shanghai) Company Limited | China |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-172864, 333-180696, 333-186789, 333-202120, 333-209756, 333-216204, 333-223155, 333-229811, 333-236565 and 333-239872) of Magnachip Semiconductor Corporation of our report dated February 23, 2022 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ Samil PricewaterhouseCoopers |
Seoul, Korea |
February 23, 2022 |
Exhibit 31.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO
SECTION 302 OF THE
SARBANES-OXLEY ACT OF 2002
I, Young-Joon Kim, certify that:
1. | I have reviewed this annual report on Form 10-K of Magnachip Semiconductor Corporation; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrants other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
(a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
(b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
(c) | Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
(d) | Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and |
5. | The registrants other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions): |
(a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and |
(b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting. |
Dated: February 23, 2022
/s/ Young-Joon Kim |
Young-Joon Kim |
Chief Executive Officer |
(Principal Executive Officer) |
Exhibit 31.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
PURSUANT TO
SECTION 302 OF THE
SARBANES-OXLEY ACT OF 2002
I, Shin Young Park, certify that:
1. | I have reviewed this annual report on Form 10-K of Magnachip Semiconductor Corporation; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrants other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
(a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
(b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
(c) | Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
(d) | Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and |
5. | The registrants other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions): |
(a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and |
(b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting. |
Dated: February 23, 2022
/s/ Shin Young Park |
Shin Young Park |
Chief Financial Officer |
(Principal Financial Officer and Principal Accounting Officer) |
Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Magnachip Semiconductor Corporation (the Company) hereby certifies, to such officers knowledge, that:
(i) the Annual Report on Form 10-K of the Company for the year ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the Report) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in the Report.
Dated: February 23, 2022
/s/ Young-Joon Kim |
Young-Joon Kim |
Chief Executive Officer |
(Principal Executive Officer) |
The foregoing certification is being furnished solely pursuant to 18 U.S.C. § 1350 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended or incorporated by reference in any registration statement of the Company filed under the Securities Act of 1933, as amended.
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
Exhibit 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Magnachip Semiconductor Corporation (the Company) hereby certifies, to such officers knowledge, that:
(i) the Annual Report on Form 10-K of the Company for the year ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the Report) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in the Report.
Dated: February 23, 2022
/s/ Shin Young Park |
Shin Young Park |
Chief Financial Officer |
(Principal Financial Officer and Principal Accounting Officer) |
The foregoing certification is being furnished solely pursuant to 18 U.S.C. § 1350 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended or incorporated by reference in any registration statement of the Company filed under the Securities Act of 1933, as amended.
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.